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Abstract
This body of work details the exploitation of an incredibly powerful neural culture
system, which enables the in vitro study of events involved in peripheral nervous system
(PNS) development.  Using a myelinating dorsal root ganglion (DRG) explant culture
system, node of Ranvier formation and maintenance and the associated generation and
maturation of myelin segments was examined.  In addition, Schwann cell (SC)
development, dynamics, and migration were extensively studied.
First, in characterizing these cultures, the discrete axonal localization of specific
ankyrin isoforms was revealed.  Ankyrins are peripheral membrane proteins that
immobilize classes of integral membrane proteins to the spectrin based-membrane
skeleton.  Ankyrins interact with proteins such as the voltage-dependent/gated sodium
channel (vgsc) and members of the L1 family of cell adhesion molecules.  These
interactions are physiologically relevant to the formation of membrane specializations
involved in axon guidance and the initiation and propagation of action potentials.
We examined ankyrinB and ankyrinG expression in cultured DRG explants, which
allowed visualization of individual axons.  AnkyrinB and ankyrinG exhibited differential
localizations to specific axonal populations.  This was evident as early as one day in vitro
and persisted over time.  In mature pre-myelinated cultures, axons having an apparent
diameter of less than 1 µm predominantly expressed ankyrinB, whereas axons having a
diameter greater than or equal to 1 µm predominantly expressed ankyrinG (based on
immunocytochemical reactivity). When myelination was induced, ankyrinG was
appropriately localized to sites of nodal development flanked by myelinating glial
processes in the large caliber axons.  These observations suggest that axons destined for
vmyelination may express a distinct complement of peripheral, and perhaps integral,
membrane proteins as compared to those observed in non-myelinated axons.  These
distinguishing features may play a role in the selection of axons for myelination.
This work was followed with defining the role axo-glial interactions play in
organizing domains along the axon being myelinated.  Nodes of Ranvier are specialized,
highly polarized axonal domains crucial to the propagation of saltatory action potentials.
In the PNS, axon-glial cell contacts have been implicated in SC differentiation and the
formation of nodes of Ranvier.  SC microvilli establish axonal contact at mature nodes,
and their components have been observed to localize early to sites of developing nodes.
However, a role for these contacts in node formation remains controversial.
Using the myelinating explant culture system, we observed that SCs reorganize
and polarize microvillar components, such as the ezrin-binding phosphoprotein 50kDa
(EBP50)/regulatory co-factor of the sodium-hydrogen exchanger isoform 3 (NHERF-1),
actin, and the activated ezrin, radixin, and moesin (ERM) family of proteins, concomitant
with myelination in response to inductive signals.  These components were targeted to the
SC distal tips where live cell imaging revealed novel, dynamic growth cone-like
behavior.  Further, localized activation of the Rho signaling pathway at SC tips gave rise
to these microvillar component-enriched “caps” and influenced the efficiency of node
formation.
Extending these findings, a more profound examination of SC dynamics was
undertaken.  This was a particularly important experimental transition, as SC motility is
crucial in the development and regeneration of the PNS.  The seemingly equivalent
bipolarity of mature SCs represents a conundrum in terms of directed motility.
vi
Fluorescence time-lapse microscopy of transfected SCs within the myelinating DRG
explants revealed a novel cycling of these cells between static, bipolar and motile,
unipolar morphologies via asymmetric process retraction and extension.  Concentrations
of PIP2 (phosphatidylinositol (4,5)-bisphosphate), activated ERMs, and EBP50
delineated the transitory asymmetry associated with the generation and neuron-like
migration of the unipolar cell.  EBP50 over-expression enhanced unipolar SC migration,
suggesting a new role for this adaptor protein in cell motility.  Further, the ERMs
themselves were found to be essential to both motility and process dynamics with ERM
disruption yielding a dysfunctional, multipolar SC phenotype.  We propose this novel
form of motility may be associated with the correct alignment and spacing of SCs along
axons prior to elaboration of the myelin sheath.
These compiled studies present significant advances in understanding and
examining axo-glial interactions in the PNS.  This work establishes the foundation for
further, novel exploration of normal PNS development and the regeneration and repair
mechanisms involved in PNS injury and disease states.
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2Myelination
Myelination is a vertebrate adaptation that involves supporting glial cells,
engaged with target nerve cells, concentrically spiraling multi-lamellar sheaths of
insulating membrane at precise intervals along the axon (reviewed in Arroyo and Scherer,
2000; Poliak and Peles, 2003; Salzer, 2003).  The individual sheaths are known as myelin
segments, which completely cover the myelinated axon with the exception of the natural
breaks present at either end of abutting, myelinating glial cells.  These interruptions are
referred to as the nodes of Ranvier.  At the nodes, voltage-gated sodium channels (vgscs)
become highly localized mediating the continued propagation of the action potential,
which originated at the axon hillock/initial segment, down the length of the axon toward
its synaptic target (Ritchie and Rogart, 1977; Shrager, 1989).
Why are these specializations critical to our nervous function?  Generally,
conduction velocity increases proportionately with increasing axonal diameter.  The
depolarizing, passive spread of current is inversely related to the product of the axial
resistance (ra) and membrane capacitance (cm) per unit length of the axon (racm).
Resistance decreases proportionately to the square of, and capacitance increases in direct
relation to, the axonal diameter.  Thus, increasing axonal diameter provides a net
decrease in racm allowing faster action potential propagation.  In practice, however, this
relationship becomes limiting in nervous system development if the maintenance of a
given cranial volume is desirable (reviewed in Kandel et al., 1991).
Myelination aids in resolving this constraint by serving to electrically insulate the
underlying region of axonal membrane.  Because the capacitance of the myelin
membrane is inversely proportional to its own thickness and is oriented as a parallel
3capacitor with the axonal membrane, the concentric wraps of the glial cell in myelination
cause a decrease in cm and thus racm.  This, in conjunction with the segmental nature of
the myelin sheath, provides for the promotion of rapid, saltatory conduction of action
potentials and allows for maximal nervous conduction velocities of up to 100 m/sec
(Waxman, 1980).  In addition, myelination dramatically conserves both space and energy
by sparing concomitant increases in axonal caliber that would otherwise be necessary to
deliver such rapid nervous impulses.  Mathematically modeled, an unmyelinated axon
would require an obligate diameter 40-times greater and consume 4000-fold more energy
than an equivalently conducting myelinated axon (Garbay et al., 2000).  Thus,
myelination has been favored evolutionarily as an adaptation to facilitate progressions
toward higher order functions and increasing neural complexity.
Differences in CNS vs. PNS myelination
Myelinated fibers can be found in both the central and peripheral nervous systems
(CNS and PNS, respectively).  Their study is of particular interest in relationship to the
host of known debilitating, demyelinating neuropathies, including multiple sclerosis and
Charcot-Marie-Tooth disease.  Although the functionality of myelin segments in both the
CNS and PNS is essentially identical, their generation and some associated properties are
specifically divergent.
In the CNS, a single oligodendrocyte is responsible for generating multiple
myelin segments, whereas in the PNS, a myelinating Schwann cell (SC) generates only
one.  Axo-glial interactions at the nodes of Ranvier are maintained by an ancillary cell,
the perinodal astrocyte, in the CNS (Black and Waxman, 1988; Raine, 1984), while
4further specializations of the SC, the microvilli, fulfill this role in the PNS (Ichimura and
Ellisman, 1991; Raine, 1982).  (Fig. 1)
The CNS myelin sheath radially organizes the tight junction protein claudin-
11/oligodendrocyte specific protein (OSP) (Morita et al., 1999).  This four
transmembrane protein influences oligodendrocyte proliferation, migration, and
differentiation and is not present in the PNS (Bronstein et al., 2000).  The SC generates a
specialized extracellular matrix (ECM) known as the basal lamina, which contains
laminin-2, entactin, type IV collagen, fibronectin, N-syndecan, and glypican (Bunge et
al., 1980; Carey et al., 1983; Mehta et al., 1985; Scherer, 1996).  The formation of the
basal lamina is associated with SC differentiation and required for myelination.
Lastly, the SC myelin segment includes the components of reflexive adherens
(Fannon et al., 1995; Menichella et al., 2001) and gap junctions (Miyazaki et al., 1995;
Scherer et al., 1995) in the cytoplasmic channel structures, known as Schmidt-Lanterman
incisures that connect the inner- and outer-most myelin layers.  These channels provide
accessible diffusion pathways enabling rapid transport of ions, secondary messenger
molecules, and metabolites.  Specifically, the calcium-dependent adhesion molecule, E-
cadherin, is involved in generating autotypic adherens junctions and is required for the
establishment and maintenance of the outer mesaxon.  However, tissue-specific gene
ablation using Cre/LoxP techniques has demonstrated appropriate nerve functionality in
the absence of E-cadherin (Young et al., 2002).
In addition, the gap junction pore-forming protein, connexin 32, is required for
normal PNS myelination.  Connexin 32 mutations disrupt the path of radial diffusion
present in myelinating SCs and are the cause of X-linked Charcot-Marie-Tooth disease
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6Figure 1 – Myelination in the CNS vs. PNS
Depicted are the interactions between myelinating glia and target axons in the CNS and
PNS.  As described in the text, a single myelinating oligodendrocyte in the CNS is
capable of generating multiple, insulating myelin segments, whereas a given myelinating
SC can form only one.  The nodes of Ranvier are devoid of myelin, but not glial contact.
These contacts are maintained by the perinodal astrocyte in the CNS and microvillar
specializations of the SC in the PNS.  Such axo-glial interactions may be crucial in the
organization and maintenance of the node.  As myelination progresses, the vgscs become
highly concentrated at the axon initial segment and at the nodes.  This facilitates action
potential initiation and propagation, respectively, enabling the transmission of electrical
stimulation to the axon’s synaptic terminal.
7(CMTX) (Bergoffen et al., 1993).  CMTX involves aberrations in the periaxonal collar
and non-compacted myelin regions and both myelin and axonal degeneration.
Interestingly, recent evidence indicates an alternate connexin, connexin 47, is expressed
in oligodendrocytes and is critical to normal CNS myelination (Menichella et al., 2003;
Odermatt et al., 2003).  Mice lacking connexin 47 display substantial abnormalities
including oligodendrocyte death, thin/absent myelin sheaths, periaxonal disruption,
vacuolation, and axonal loss.
Myelinated nerve fiber domain organization
Considerable effort has been focused on defining the morphologic and molecular
specializations associated with not only the radial but longitudinal organization of the
myelin segments (Fig. 2A).  As described above, nodes of Ranvier flank each myelin
segment.  The intervening myelinated region is referred to as the internode.  The length
of the internode, and thus the nodal spacing, increases proportionally with respect to the
diameter of the underlying axon.  The nodes are situated at a distance of approximately
100-times that of the axonal diameter (Friede and Bischhausen, 1980; Friede et al., 1981;
Smith et al., 1982a).  This suggests that intrinsic axonal determinants govern nodal
positioning.  However, examination of the hypomyelinating claw paw mutant suggests
glial signaling involvement.  This autosomal recessive mutation delays the onset of PNS
myelination (Henry et al., 1991).  Sciatic nerves from these animals display prolonged
maintenance of an unmyelinated state and atypical patterns of myelin maturation.
Initially, myelination generally appears normal but results in drastically shortened
internodes (Koszowski et al., 1998).  This suggests that the elongation of the myelinating
SC determines the internodal length independent of axonal caliber.  Definitive
NodeParanode
Juxta-
Paranode
Internode
Longitudinal domain organization along a myelinated nerve fiber
PNS
CNS Perinodal Astrocyte
Process
Schwann Cell
Microvilli
A
axon
outer mesaxon
inner mesaxon
Cross-section through PNS myelinating nerve B
Figure 2 -Features of myelinated fibers
Schwann cell nucleus
9Figure 2 – Features of myelinated fibers
A) Shown is a diagrammatic representation of the longitudinal organization along a
myelinated fiber in both the CNS and PNS.  The illustration shows a heminodal region in
association with either the perinodal astrocyte process or the SC microvilli.  Immediately
adjacent to the node is the paranode.  This region is hallmarked by the presence of
cytoplasm-filled glial loops, which are involved in forming tight, septate-like junctions
with the associated axonal domain.  The next evident domain is the juxtaparanode
followed by the most prevalent region of the myelin segment, the internode.  B)
Illustrated is a cross-section through a PNS myelinated fiber, showing the general
positioning of the inner and outer mesaxons.  During myelination, the inner lip of the
glial cell, the inner mesaxon, advances forming concentric membrane wraps that continue
to increase the myelin membrane thickness.  Figure adapted with permission from Poliak
and Peles, Nat Rev Neurosci. 2003 Dec;4(12):968-80.
10
implication or exclusion of either mechanism controlling internodal length, axonal
intrinsic or extrinsic, awaits determination.
Although the mechanisms governing nodal genesis still remain unclear, the nodes
are known to be enriched in particular subsets of proteins.  As indicated, vgscs become
highly localized to the axonal surface of the node (>1200 channels/µm2 as compared to
<25 channels/µm2 along the internode) (Ritchie and Rogart, 1977; Shrager, 1989).  These
channels undergo a developmental switch from isoform Nav1.2 to Nav1.6, the
significance of which is not understood (Boiko et al., 2001; Kaplan et al., 2001).  Other
axonal proteins found at the nodes include cell adhesion molecules (NrCAM and
neurofascin-186 kDa) (Davis and Bennett, 1993; Davis et al., 1996; Lambert et al., 1997),
cytoskeletal elements (ankyrinG and βIV-spectrin) (Berghs et al., 2000; Komada and
Soriano, 2002; Kordeli et al., 1995), and a potassium channel (Kv3.1 in the CNS and
Kcnq2 in the PNS) (Devaux et al., 2003; Devaux et al., 2004).
Considering the glial contribution to the node of Ranvier, contacts are maintained
by the SC microvilli in the PNS or the perinodal astrocyte in the CNS.  Of the two, the
SC microvilli have been better characterized in terms of their molecular constituents.
These fine projections have been shown by electron microscopy to emanate from the
outer edge of the SC and form an axonally encompassing collar (Waxman and Black,
1987).  The microvilli themselves are characterized by the presence of all three of the
actin cross-linking family of ERM (ezrin, radixin, moesin) proteins (Melendez-Vasquez
et al., 2001; Scherer et al., 2001).  In addition, the ERM-binding phosphoprotein 50 kDa
(EBP50) is also present (Gatto et al., 2003; Melendez-Vasquez et al., 2001).  These
components may serve as adaptor molecules linking integral membrane components to
11
the microvillar cytoskeleton.  High-resolution studies have demonstrated filaments, 40-80
nm in length, directly coupling the SC microvilli to the nodal axolemma (Ichimura and
Ellisman, 1991).  This indicates the potential existence of microvilli-localizing, cognate
glial receptors for nodally clustered axonal components. (Fig. 3)
Beyond the node, additional defining structural and molecular detail is
discernable along the internode.  As the glial cell initiates myelination, it begins to wrap
membrane around the circumference of the axon with its inner lip continually advancing
(Bunge et al., 1989).  The glial surfaces either apposing the ECM or the axon itself are
referred to as abaxonal/basal and adaxonal/apical, respectively, and the associated
terminations of the spiraling glial cell are known as the outer and inner mesaxons (Fig.
2B).  After approximately 1.5 wraps around the axon, a characteristic early, non-compact
myelin protein, myelin-associated glycoprotein (MAG), is expressed (Martini and
Schachner, 1986; Martini and Schachner, 1988).  After multiple turns have been
achieved, compaction of these membrane layers begins.  The myelin constituent, protein
zero (P0), facilitates this compaction.  P0 is an abundant, adhesive protein that forms
tetramers in cis, and these multimers interact homophilically in trans bringing the
membranes in close apposition (D'Urso et al., 1990).  In addition, myelin basic protein
(MBP) becomes detectable, which is present only in compact myelin (Sternberger et al.,
1978).
As compaction proceeds, the majority of cytoplasm is extruded out toward the
lateral borders of the glial wraps forming the paranodal loops adjacent to the node of
Ranvier.  The paranode itself is distinct in terms of its molecular composition and its
proposed functionality.  This region’s unique character is defined by paranodal/septate-
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Figure 3 - Axo-glial interactions in the PNS
As indicated in the text, the molecular composition of the nodes of Ranvier and
paranodes of myelinated axons is emerging.  In the PNS, the myelinating SC maintains
contacts at the node via microvilli, which are enriched in actin filaments, ERM family
proteins, EBP50, and certain potassium channels.  On the axonal side of the node, the
glial cell may serve to organize clusters of membrane proteins, such as the cell adhesion
molecules, neurofascin 186 kDa and NrCAM, and vgscs of the isotypes 1.2 and 1.6.  The
underlying axonal cytoskeleton at the node is enriched in ankyrinG and βIV-spectrin.
Adjacent to the node are the non-compacted paranodal loops.  These structures are
involved in mediating the paranodal, septate-like junctions via interactions between
axonally derived contactin/Caspr complexes with glially contributed neurofascin 155
kDa.  Immediately beyond the paranode lies the juxtaparanodal region, which marks the
lateral border of the compact, myelinated internode and maintains concentrations of the
potassium channels, Kv1.1 and 1.2.
14
like junctions, which are hypothesized to serve as molecular sieves in the membrane
restraining the lateral mobility of certain intra-membrane components (Pedraza et al.,
2001; Trapp and Kidd, 2000).  In addition, the junctions also limit the diffusion of small
molecules and ions.  As the paranode is situated between the vgsc-enriched node of
Ranvier and the potassium channel-enriched juxtaparanode, this functionality is essential
to the electrical isolation of these two active domains.  The diffusion barriers are
maintained by immediate juxtaposition of the axonal and glial membranes (3-5 nm
periaxonal space at the paranode vs. 15 nm along the internode (reviewed in Salzer,
2003)) via the interactions of axonal heterodimers of Caspr1/paranodin and contactin
with their glial partner, neurofascin 155 kDa (Boyle et al., 2001; Charles et al., 2002;
Einheber et al., 1997; Tait et al., 2000).
Caspr is a member of the neurexin superfamily of proteins known to mediate
intercellular adhesion and communication.  Caspr also contains both a FERM (4.1, ezrin,
radixin, moesin) and SH3 domain (Peles et al., 1997).  Thus, it is situated to mediate the
translation of extracellular events to the underlying cytoskeleton and participate in
organizing responsive signaling complexes at the paranodal membrane.  The interaction
of Caspr with contactin, a glycosyl-phosphatidylinositol (GPI)-linked glycoprotein, is
critical for its appropriate processing and targeting (Bonnon et al., 2003; Gollan et al.,
2003).  These c i s-interactors complex heterophilically with the glial cell adhesion
molecule, neurofascin 155 kDa, via the direct binding of contactin and neurofascin
(Charles et al., 2002; Gollan et al., 2003) (Fig. 3).  This was demonstrated by the over-
expression of Caspr inhibiting the interaction.  Inhibition resulted from the biosynthetic
association of Caspr with contactin forcing the expression of a low molecular weight,
15
endoglycosidase H-sensitive isoform of contactin at the cell surface.  This low molecular
weight variant remains associated with Caspr but is unable to bind neurofascin 155 kDa
(Gollan et al., 2003).
Advances in the field will require further dissection of the exact functionality of
the junctions formed by these intermolecular associations.  However, their proposed role
as diffusional barriers has been well documented.  This is best evidenced by analysis of
mutations that result in disrupted paranodal regions, which include the engineered
contactin and Caspr1 null mice (Bhat et al., 2001; Boyle et al., 2001).  The nerves of
these animals display elongated nodes of Ranvier, as indicated by diffuse vgsc clusters.
In addition, the paranodes maintain the irregular appearance of potassium channels
(Kv1.1 and 1.2), Caspr2, and the GPI-linked cell adhesion molecule TAG-1.  These
proteins are normally restricted to the adjacent juxtaparanodal region (Arroyo et al.,
2001; Poliak et al., 1999).  Other mutations impairing paranodal development include the
CGT (UDP-galactose ceramide galactosyl-transferase) and CST (cerebroside
sulfotransferase) targeted gene disruptions.  These enzymes are necessary for the
formation of myelin glycolipids, including galactocerebroside (GalC) and sulfatide.
These animals also display a loss of lateral diffusional control in their myelinated fibers,
and their aberrant phenotypes specifically implicate glycolipid synthesis in junctional
complex assembly (Honke et al., 2002; Poliak et al., 2001).
Effect of myelinating glia on axonal properties
Axo-glial interactions not only serve to physically specify regional boundaries but
also allow the myelinating glial cells to exert marked biochemical and physiological
influences on their associated axon.  For example, increased axonal diameter is promoted
16
along the length of the compact, myelinated segment, with caliber reduced by as much as
80-85% in paranodal and nodal regions (Berthold, 1996; Sward et al., 1995).  Further,
these alterations in axonal diameter are directly linked to glial-induced cytoskeletal
rearrangements.
The status of the axonal neurofilament network significantly influences axonal
caliber and is itself influenced by myelination status.  Increased neurofilament
phosphorylation allows for enhanced separation, providing increases in axonal diameter.
Neurofilaments residing in either non-compacted or unmyelinated regions (i.e. paranodes
and nodes, respectively) are reduced in total amount, more ordered, and less
phosphorylated (de Waegh et al., 1992; Martini, 2001; Starr et al., 1996).  The functional
consequence of these factors is axonal constriction.  In accordance with these findings,
along the myelinated internodal region, neurofilament phosphorylation and axonal caliber
are increased.  Transgenic mice, one of which utilizes the P0 promoter to drive diptheria
toxin production in myelinating SCs, implicate the direct influence of the myelinating
glial cell on these factors.  These animals display severe hypomyelination that is coupled
with dramatic decreases in neurofilament phosphorylation and axonal diameter (Cole et
al., 1994).
The myelinating glial cell also affects the axonal microtubule cytoskeleton, which
again is best demonstrated by examining several available hypomyelinating mutants.  The
PNS myelin mutant trembler is deficient in a compact myelin component, the peripheral
myelin protein 22 kDa (PMP22).  Demyelinated segments in these mice exhibit decreases
in axonal caliber, depressed neurofilament phosphorylation, and microtubule
cytoskeleton modifications.  The stability of the trembler axonal microtubule network is
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decreased and the composition and phosphorylation of axonal microtubule-associated
proteins, including tau, MAP1A, and MAP1B, are altered (Kirkpatrick and Brady, 1994).
In the CNS myelin mutant shiverer, which is deficient in MBP, microtubule stability is
reduced.  However, microtubule density is increased, as a result of increased tubulin
expression (Kirkpatrick et al., 2001).
Axo-glial interactions and node of Ranvier formation and maintenance
The effect of the glial cell on certain axonal properties, including caliber via
cytoskeletal modification, remains largely undisputed.  However, one of the most
significant controversies lies in whether axo-glial interactions are required for the
formation and maintenance of the nodes of Ranvier.  Is node formation glial cell-guided,
or do axonally-derived intrinsic determinants govern this process?  Examined in both the
CNS and PNS, contradictory findings leave these key questions unsatisfactorily
answered.
 The hypothesized dependence of nodal development on direct glial association
has been well demonstrated.  Using vgsc clustering as an indicator of nodal genesis, vgsc
aggregates have been shown to faithfully arise in close proximity to MAG-positive SC
processes (Vabnick et al., 1996).  Transgenic mouse models exploiting the P0 promoter
have shown that adherence of SCs is required for vgsc clustering into focal nodal regions,
and these SCs must have reached a committed myelinating stage (Vabnick et al., 1997).
In addition, remyelination studies in the induced PNS disease state of Experimental
Allergic Neuritis (EAN), which is used as a model for immune-mediated inflammatory
demyelinating diseases like Guillan-Barre syndrome and multiple sclerosis, demonstrate
that vgsc reorganization depends upon SC positioning (Novakovic et al., 1998).  Studies
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in cultured dorsal root ganglia (DRGs) demonstrate the preclusion of vgsc and ankyrinG
clustering in the presence of conditioned media isolated from myelinating cultures.  The
absence of clusters was also noted on suspended axonal bundles, or fascicles, despite
their close proximity to other myelin segments (Ching et al., 1999).  Further, the MBP-
TK transgenic mouse, which undergoes specific oligodendrocyte ablation upon FIAU (1-
(2-deoxy-2-fluoro-β-δ-arabinofuranosyl)-5-iodouracil) treatment, retains axonal nodal
component protein levels in the complete absence of their clustering (Mathis et al., 2001).
Alternatively, compelling evidence also indicates a glial-independence associated
with node formation.  Studies of lysophosphatidyl-choline treated, demyelinated axons
demonstrate foci of directed current prior to remyelination, indicating vgsc reorganization
in the absence of axo-glial interactions in the PNS (Smith et al., 1982b).  The dystrophic
mouse of the strain 129/ReJ-Lama2dy, which is deficient in the expression of merosin
(laminin α2), organizes vgsc clustering in amyelinated regions that implicate SC
independent events (Deerinck et al., 1997).  CNS studies indicate that soluble
oligodendrocyte-derived factors promote node formation in cultured retinal ganglion cell
axons (Kaplan et al., 1997).  Further, in the jimpy mutant mouse, which is altered in its
myelin proteolipid protein (PLP) expression, oligodendrocytes spontaneously degenerate,
but nodal clusters of vgscs and ankyrinG are still observed (Mathis et al., 2001).
The myelinating SC
As this body of work will focus on the specialized axo-glial contacts maintained
in the PNS, we shall concentrate on the myelinating SC.  SCs are derived from multi-
potent neural crest cells, which arise from the neuroepithelium of the closing neural tube
and begin their lateral and ventral migratory streams at embryonic day 9-10 (E9-10) in
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the rat (reviewed in Lobsiger et al., 2002; Mirsky and Jessen, 1999).  By E12-14, these
cells have become lineage specified, with certain populations directed toward gliogenesis
by β-neuregulin and Notch signaling.  These cells serve as the SC precursors (Jessen and
Mirsky, 1991; Jessen and Mirsky, 1997; Jessen and Mirsky, 1998).  Flattened, markedly
migratory, and highly mitotic, SC precursors can be identified in association with
fascicles of extending axons of the PNS (Fig. 4A).  Their molecular signature is defined
by the expression of the low-affinity neurotrophin receptor p75, the cell adhesion
molecule L1, the intermediate filament protein nestin, and the growth-associated protein
43 (GAP43) (Jessen et al., 1994; Jessen and Mirsky, 1998; Stewart et al., 1992).  They
also maintain low levels of P0 (Bhattacharyya et al., 1991), PMP22 (Hagedorn et al.,
1999; Pareek et al., 1993), and the transcription factor 0ct-6/SCIP (Blanchard et al., 1996;
Monuki et al., 1989).  Further, SC precursors will apoptose if deprived of axonal contact
without introducing exogenous trophic support due to the lack of discrete autocrine
survival loops (Jessen and Mirsky, 1999).
At E16-16.5, SC precursors undergo differentiation into committed early/
immature SCs (Jessen et al., 1994).  These bipolar cells are distinguished by the
expression of the small calcium binding protein, S100.  In addition, they present the
sulfoglycolipid antigen 04 (Mirsky et al., 1990), express the intermediate filament protein
GFAP (glial fibrillary acidic protein) (Jessen et al., 1990), and upregulate the
transcription factors, Oct-6 and Krox20 (Arroyo et al., 1998; Lobsiger et al., 2001).  In
contrast to the SC precursors, the early SCs are able to fully withstand axonal deprivation
(Jessen and Mirsky, 1999).  Further, these early SCs continue to divide, with a mitotic
SC
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Figure 4 – SC development and differentiation
Detailed here are the developmental stages leading to the differentiation of the mature
SC.  A) Upon encountering bundles/fascicles of axons, the neural crest-derived SC
precursors have a flattened morphology and are highly migratory (E12-14 in rat).  These
cells can be isolated from their axonal partners, however, due to a lack of autocrine
survival loops will apoptose shortly thereafter.  B) The SC precursors transition to
early/immature SCs assuming their typical bipolar spindle shape (E16-16.5).  These
S100-reactive cells are less migratory than the SC precursors; however, they actively
infiltrate the axon bundle initiating axon sorting and engagement.  At this developmental
stage, SCs may be deprived of axonal contact to permit isolated SC culture.  Of note,
there is a reversibility of this early bipolar phenotype in vitro.  The reversion of these
cells to the precursor morphology is highly dependent upon culture density and passaging
frequency.  C) The mature SCs can assume either a myelinating or non-myelinating role
in the peripheral nerve (P1-).  Initiation of myelination involves the 1:1 association of the
SC with its target axon, SC elongation, and formation of the initial membrane wraps
around the axon.  Having achieved this positioning, the SC then commences the
myelination program.  However, not all SCs are destined to myelinate.  Non-myelinating
SCs interact with small bundles of axons (shown here in pink) and ensheathe them with
simple membrane extensions.
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peak at E19-20, and infiltrate axon bundles preparing to assume their terminally
differentiated state (Stewart et al., 1993) (Fig. 4B).
Neonatally, SC maturation culminates with the generation of two functional
categories of SCs, myelin- and non-myelin forming (reviewed in Mirsky and Jessen,
1996).  Myelinating SCs segregate larger caliber axons (>1 µm diameter) until achieving
the appropriate 1:1 relationship, as each SC will establish only one myelin segment.
Basal lamina formation and myelin deposition then commence in response to presently
unidentified inductive cues.  The non-myelin forming SCs also establish a basal lamina
but only ensheathe and separate groups of smaller diameter axons with simple, membrane
extensions (Fig. 4C).
Adaptor proteins in the PNS – ankyrins, ERMs, and EBP50
Myelination involves morphologic and molecular specializations of both the
myelinating glial cell and its target axon.  These molecular alterations occur at the
membranes of the axo-glial interface and the underpinning cytoskeletal network.  Here,
we will discuss the importance of certain adaptor proteins in PNS myelination that will be
of particular relevance in the presented studies.
Ankyrins
Crucial to the functionality of the axonal cytoskeleton is the regulated expression
of the ankyrins.  Ankyrins are membrane adaptor proteins that immobilize integral
proteins linking them to the spectrin-based membrane skeleton (reviewed in Bennett and
Chen, 2001; Bennett and Lambert, 1999).  Ankyrins are modular proteins that maintain
several conserved domains, including NH2-terminal membrane-binding ANK repeats (89-
95 kDa), a spectrin-binding domain (62 kDa), and a COOH-terminal death domain (12
23
kDa) (Lambert et al., 1990; Lux et al., 1990; Otto et al., 1991).  The ANK repeats
themselves are 33-amino acid repeats, of which there are 24 tandemly arrayed in the
ankyrins.  These 24 ANK repeats are further structured such that four globular
subdomains of six repeats each are generated (Michaely and Bennett, 1993).  The largest
ankyrin isoforms are selectively found in the axons of CNS and PNS neurons and contain
considerable insertions separating the spectrin-binding and death domains.  These
variable, filamentous tail regions may facilitate interactions in a tissue- and isoform-
specific manner and, if fully extended, could be as long as 0.5 µm. (Fig. 5)
The ankyrin family of proteins is encoded by three distinct genes, ANK1, ANK2,
and ANK3.  The corresponding polypeptides are referred to as ankyrinR, ankyrinB, and
ankyrinG, respectively.  Various isoforms of these proteins are often present due to
developmentally regulated, tissue-specific, alternative mRNA processing (Fig. 5).
The multi-valency of ankyrin (Michaely and Bennett, 1995) allows it to take part
in the assembly of specialized regions of the plasmalemma implicated in processes such
as axon guidance and the initiation of action potentials.  To this end, ankyrins link a
variety of proteins to the spectrin-based membrane skeleton.  These include cell adhesion
molecules (Bourrguignon et al., 1995; Davis and Bennett, 1993; Kalomiris and
Bourguignon, 1988; Zhang et al., 1998), ion channels and exchangers (Li et al., 1993;
Srinivasan et al., 1988), and calcium-release channels (Bourguignon and Jin, 1995;
Bourguignon et al., 1993).
Sequence motifs that mediate ankyrin-membrane protein interactions have begun
to emerge.  A 5-amino acid sequence (FIGQY) is obligatory and phosphorylation-state
dependent for the ankyrin binding of the immunoglobulin (Ig)/ fibronectin III (FNIII)
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Figure 5 – Domain structure of ankyrin isoforms
Illustrated is the generalized domain structure of the ankyrin family of membrane adaptor
proteins.  Ankyrins maintain several conserved domains, including NH2-terminal
membrane-binding ANK repeats (89-95 kDa), a spectrin-binding domain (62 kDa), and a
COOH-terminal death domain (12 kDa).  Variable domains often utilized result from
alternative mRNA processing and include an o-GlucNAc-glycosylated serine/threonine-
rich region and a filamentous, extended tail domain.  The ankyrin family is the product of
three distinct genes with their resulting polypeptides known as ankyrinG, ankyrinB, and
ankyrinR.  Shown is the organization and domain usage of the various ankyrin isoforms.
While ubiquitously expressed, the ankyrins are specifically enriched in brain, kidney,
muscle, and erythrocytes, as indicated.
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family of neural cell adhesion molecules, including L1, NrCAM, and neurofascin (Zhang
et al., 1998).  Further, a highly conserved 9-amino acid motif ((V/A)P(I/L)AXXE(S/D)D)
has recently been identified, which confers ankyrin binding to the α-subunit of vgscs
(Lemaillet et al., 2003).  However, the specificity of interactions between various
isoforms of ankyrin and their membrane-associated binding partners remains unclear.
ERMs
ERM (ezrin, radixin, moesin) proteins are critical in the formation of specialized
plasma membrane domains.  In particular, ERMs are highly enriched in protrusive
structures, like microvilli and membrane ruffles, where they link the cell membrane to the
actin cytoskeleton.  These three proteins are very closely related, sharing 75-78% overall
identity, and are members of the band 4.1 super-family.  As such, the ERMs contain the
shared NH2-terminal FERM (4.1, ezrin, radixin, moesin) domain, which is 32% identical
to the first 300 residues of the founding family member, erythrocyte band 4.1 (reviewed
in Bretscher et al., 2000; Bretscher et al., 2002; Bretscher et al., 1997).  In band 4.1, this
domain connects the actin/spectrin cytoskeleton to the membrane protein glycophorin C
(Anderson and Lovrien, 1984; Marfatia et al., 1995; Marfatia et al., 1994) and confers
membrane-anchoring properties to the ERM family.
The ERM proteins bind integral membrane proteins, i.e. CD44 (Tsukita et al.,
1994), and other adaptor molecules, i.e. EBP50 (Reczek et al., 1997), via their NH2-
terminal regions and to actin through their COOH-terminal domains (Pestonjamasp et al.,
1995; Turunen et al., 1994).  However, the capacity of the ERMs to engage in these
bifunctional, cross-linking interactions is dependent upon the relief of their intrinsic
conformational regulation and their phosphorylation state.  These proteins are maintained
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in a dormant, “closed,” non-phosphorylated state when the ERMs’ NH2-terminal 296
residues (co-incident with the FERM domain) interact with the COOH-terminal 110
residues (amino acids 467-577 in ezrin).  These self-associating domains are known as
the NH2- and COOH-ERM association domains (N-ERMAD and C-ERMAD,
respectively) and mediate both intra- and inter-molecular, high affinity interactions (Gary
and Bretscher, 1995). (Fig. 6)
Activation of these proteins and the unmasking of their membrane- and actin-
binding regions then require the physical separation of the ERMAD domains and
stabilizing phosphorylation.  First, ERMs interact with phosphatidylinositol (4,5)-
bisphosphate (PIP2).  PIP2 binds to the N-ERMAD region and suppresses the intra-
molecular auto-inhibition (Niggli et al., 1995).  This was demonstrated by the enhanced
binding of full-length radixin to the cytoplasmic tail of CD44 (Hirao et al., 1996) and of
ezrin to ICAM-1 and –2 (Heiska et al., 1998) in the presence of this phosphoinositide.
However, PIP2-ERM binding is not itself sufficient to promote ERM activation,
suggesting that PIP2 binding may induce a conformational shift toward an “open” state
that renders the ERM proteins more susceptible to phosphorylation.
The recognized, activating ERM phosphorylation site is that of a conserved
COOH-terminal threonine residue (ezrin T567, radixin T564, and moesin T558),
originially identified in moesin during platelet activation by thrombin  (Nakamura et al.,
1995).  The phosphorylated, active versions of these proteins mediate the organization of
the cortical actin-based cytoskeleton and are specifically concentrated in microvilli and
other cell surface structures (Yonemura and Tsukita, 1999).  Phosphorylation at this key
threonine suppresses N-/C-ERMAD interactions (Matsui et al., 1998) and is
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Figure 6 – ERM and EBP50 structure and function
A prototypical microvillus is shown detailing the interactions between core actin
filaments, ERMs, EBP50, and integral membrane proteins.  This schematic demonstrates
that the ERM-membrane linkages may be direct, as with CD44, or indirect via EBP50, as
with the CFTR.  Also detailed is the structure of the ERM family proteins harboring
globular NH2-terminal (FERM) domains, α-helical central regions, and charged COOH-
terminal domains.  The identity of these regions in radixin and moesin are given with
respect to ezrin.  The domain organization of EBP50 is also shown, detailing its two PDZ
domains and its COOH ERM-binding region.  As described in the text, EBP50 will only
interact with activated, phospho-ERMs.  A proposed mechanism of ERM activation
suggests a two-stage process whereby PIP2 alleviates the intrinsic conformational
inhibition achieved by N- and C-ERMAD interaction allowing for COOH-terminal
threonine phosphorylation by either ROCK or PKC.
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accomplished by at least three different kinases, Rho-kinase (ROCK) (Matsui et al.,
1998; Tran Quang et al., 2000), protein kinase Cα (PKCα) (Ng et al., 2001), and PKCθ
(Simons et al., 1998).  The combination of electrostatic and steric effects induced by
T567/T564/T558 phosphorylation weakens the affinity of the NH2- and COOH-terminal
regions for one another enabling the unmasking of the functional ERM domains (Pearson
et al., 2000).
EBP50
While activated ERM proteins have been shown to participate in direct
membrane-cytoskeleton cross-linking, ERM-binding adaptor proteins may also be
employed to accomplish these linkages indirectly.  The ERM-binding phosphoprotein 50
kDa (EBP50)/NHE3 regulatory exchange factor (NHERF) is one such scaffolding
protein, originally identified in the renal brush border, placental microvilli, and brain
(Reczek et al., 1997; Weinman et al., 1993).  EBP50 is a 357-residue polypeptide that
contains two PDZ (PSD-95/DlgA/ZO-1) domains.  In addition, the COOH-terminal 30
amino acids of EBP50 comprise an ERM-interacting region that tightly binds the N-
ERMAD of activated, phospho-ERMs.  (Fig. 6)
EBP50 binds a multitude of membrane proteins via its PDZ domains, which
recognize specific consensus sequences at the extreme COOH-termini of their targets.
These consensus sequences have been defined as  -X-S/T-R/Y-L for PDZ1, with the
experimentally determined optimal sequence being –D-T-R-L, and -S-S/T-W-L for PDZ2
(Wang et al., 1998).  Containing such sequences, EBP50 interacts with, apically targets,
and aids in maintaining the localization of the β2-adrenergic receptor (Hall et al., 1998a;
Hall et al., 1998b), platelet-derived growth factor receptor (Maudsley et al., 2000), and
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cystic fibrosis transmembrane receptor (CFTR) (Short et al., 1998; Wang et al., 1998).
EBP50 has also been implicated in the regulation and intracellular trafficking of its
associated proteins.  Thus, EBP50 could mediate the recruitment and retention of integral
membrane proteins to areas enriched in activated ERMs, such as the microvilli.
Thesis aim
As previously indicated, this thesis will examine the axo-glial contacts maintained
by the SC microvilli, hypothesizing that their establishment and stability are in fact vital
to appropriate myelination.  Pursuant to this end, we will explore several facets of PNS
myelination, including molecular alterations in axonal and SC composition upon the
induction of myelination, axo-glial interactions involved in node of Ranvier formation
and maintenance, myelin segment generation and maturation, and SC motility.  These
studies will shed new light on the dramatic events associated with initiating peripheral
myelination and the dynamics of the myelinating SC.
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Chapter 2
Methodologies
DRG and SC Culture:
Maintenance
Transfection
Retroviral Infection
Immunostaining
Live Cell Imaging
Teased Sciatic Nerve Fibers
EBP50 Construct and Antibody Generation
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Presented is a detailed accounting of the methodologies and manipulations that
were employed to enable the study of events in PNS myelination.  Of note, our primary
experimental system centers on myelinating, explanted dorsal root ganglia (DRGs).
DRGs contain the cell bodies of peripheral sensory neurons that serve as conduits
between the periphery and spinal cord.  Also within the DRG are specialized glial cells
known as satellite cells, which encapsulate the somal region of the sensory neurons
(Wood, 1976).  The satellite cells retain a multi-potency that allows them to be
differentiated in vitro into myelinating cells that are functionally and phenotypically
indistinguishable from SCs (Hagedorn et al., 2000a; Hagedorn et al., 2000b).  This glial
conversion is convincingly demonstrated by the satellite cells responding to axonal
regeneration and outgrowth in DRG explants by the specific expression of the SC-
restricted transcription factor, Krox20 (Murphy et al., 1996).  (For purposes of clarity
then, DRG-originating glial cells in the in vitro explants will henceforth be referred to as
SCs.)  This culture system permits the association of tissue-endogenous, myelinating glial
cells with target axons allowing for a physiologic approximation of PNS developmental
specialization.
DRG Explant and SC Cultures
DRG explants were cultured essentially as previously described (Howe and
McCarthy, 1998).  Spinal cords and associated DRGs were dissected out of euthanised
Wistar rat embryos (E16) (Charles River, North Wilmington, MA) and rinsed in Hank’s
Balanced Salt Solution (HBSS) with calcium (1.2 mM) and magnesium (0.8 mM)
(Sigma-Aldrich, St. Louis, MO) supplemented with 5% fetal bovine serum (FBS), 50
U/mL penicillin, and 50 µg/mL streptomycin.  Ganglia were trimmed of spinal roots,
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rinsed with HBSS (no serum), removed, and plated into standard feed (Basal Eagle’s
Medium (BME) (Sigma) including ITS+ supplements (Discovery Labware, Inc.,
Bedford, MA), 0.2% BSA, 10 mM HEPES, 498 mg/dL D-glucose, 100 ng/mL 2.5S NGF
(Discovery Labware, Inc.), 50 U/mL penicillin, and 50 µg/mL streptomycin).  Coverslips
(Carolina Biologicals, Burlington, NC) were coated with 0.4 mg/mL Matrigel in BME
(Discovery Labware, Inc.) and 10 µg/mL poly-D-lysine (Sigma) then maintained on
Teflon circles (American Durafilm, Holliston, MA).  After approximately 21 days,
cultures were supplemented with 15% FBS and 50 µg/mL ascorbate to induce
myelination (Eldridge et al., 1987).  Cultures were incubated at 37°C in humidified 5%
CO2/95% room air with regular feeding every other day.  In some instances, media also
included various combinations of lysophosphatidic acid (LPA) (1 µM) (Sigma) and the
Rho-kinase inhibitor, Y-27632, (2-20 µM) (Calbiochem-Novabiochem Corp., San Diego,
CA).  (Fig. 7)
Isolated SCs were cultured according to the Brockes Method (Brockes et al.,
1979).   P1 rat pups were euthanized and their sciatic nerves removed.  The nerves were
then incubated with 0.1% collagenase (Sigma) in L-15 for 30 minutes at 37°C followed
by 0.1% collagenase with 0.25% trypsin for 30 minutes 37°C.  After rinsing with
DMEM+10% FBS the nerves were triturated and plated into the same medium in an
untreated 100 mm culture dish.  The next day 10-5 M 1-(β-D-arabinofuranosyl)cytosine
(AraC) (Calbiochem) was  added.  After three days of this anti-mitotic treatment, the
AraC was washed out and the cells were allowed to recover for 24 hours in DMEM+10%
FBS.  Anti-Thy1.1 (clone TN-26) (1:100 in DMEM) and rabbit complement sera HLA-
ABC (Sigma) (1:1 in DMEM) treatment followed to remove residual fibroblasts.
Addition of serum and ascorbate.
Axon outgrowth and migration
of pre-myelinating cells
(1-7 DIV)
Morphogenesis of
myelinating phenotype
(7-21 DIV)
Onset of myelination and
early node formation
(21-28 DIV)
Formation of compact
myelin and node maturation
(28- DIV)
Figure 7 – Model - DRG culture establishment
DRG
growth cone glial cells 
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Figure 7 – Model - DRG culture establishment
These studies employ DRG explants as models for myelination and node formation.
DRGs are removed from the spinal cords of E16 rat embryos.  Upon plating, a rapid
phase of axonal outgrowth triggers the migration and proliferation of a pre-myelinating
glial population.  These cells undergo differentiation toward a myelinating phenotype,
including the assumption of a markedly bipolar morphology.  Myelination is induced
upon the introduction of serum and ascorbate to the culture media.  As the cultures are
allowed to mature, molecular markers indicating myelination and node formation are
readily detected.
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Cultures were then maintained in Primaria tissue culture flasks (Becton Dickinson,
Franklin Lakes, NJ) with twice weekly feeding of DMEM+10% FBS.  Expansion could
be facilitated by the addition of 4 µM forskolin and 20 µg/mL bovine pituitary extract
(Sigma).  However, this treatment converted the cells from their bipolar spindle shape to
a flattened, more fibroblastic looking morphology.  Thus, expediting SC expansion was
not routinely performed.
Explant Transfection
Explants were transfected using Lipofectamine PLUS (Invitrogen, Grand Island,
NY).  Cultures were treated for 24 hours prior to transfection with media of choice
(Pedraza and Colman, 2000).  One microgram of DNA per coverslip was used, and the
DNA/PLUS (3.5 µL)/Lipofectamine (2.8 µL) complexes were incubated with the cultures
for 3-4 hours in unsupplemented BME.  The transfection mixture was then removed.  The
cultures were rinsed once with BME and returned to the appropriate medium.
Explant Retroviral Infection
Retroviruses were generated using ecotropic Phoenix cells (a gift of Gary Nolan,
Stanford Univeristy School of Medicine, Stanford, CA).  These cells were treated with
selective feed, DMEM containing 10% FBS, 200 µg/mL hygromycin and 2 µg/mL
diptheria toxin (Sigma), for 1 week and then allowed to recover in DMEM+10% FBS for
1 week prior to transfection with retroviral construct of interest [herein, either MSCV2.2-
ires-GFP (gift of Stephen Jones, University of Massachusetts Medical School, Worcester,
MA) or pBMN-ires-GFP (gift of G.N.)].  These cells were seeded in 100 mm culture
dishes such that they would be 70% confluent upon transfection.  Using 20 µg DNA/32.5
µL PLUS reagent/67.5 µL Lipofectamine, cultures were transfected overnight in
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unsupplemented DMEM.  The next day, the medium was replaced with 8 mL of
DMEM+10% FBS.  Cultures were allowed to produce viral particles for 48 hours.
Culture supernatant was then harvested and either spun for 5 minutes at 500 g or passed
through a 0.45 µm filter to remove cellular debris.  Virus-containing media were
aliquoted, flash frozen, and stored at –80°C.
For DRG infection, three consecutive days of retroviral exposure (d3-5 in vitro)
were allowed.  DRG explants were incubated with 1 mL retroviral medium supplemented
with 4 µL Lipofectamine for 4 hours.  Coverslips were then rinsed twice with
unsupplemented BME and returned to standard feed.
DRG Explant and SC Immunostaining
For explant staining, which included probing for myelin components, explants
were fixed for 10 minutes at 4°C in 4% paraformaldehyde/4% sucrose in PBS, pH 7-7.4.
After washing with PBS, cultures were blocked with 10% BSA in PBS+0.2% triton X-
100 (PBS-T) for 1 hour at 37°C.  Primary antibodies were then diluted in 2% BSA in
PBS-T and incubated for 1-2 hours at 37°C.  Coverslips were washed with PBS-T;
secondary antibodies, also diluted in 2% BSA in PBS-T (1:1000), were then added and
incubated for 1 hour at 37°C.  After washing with PBS-T followed by PBS alone and a
water rinse, coverslips were mounted using Vectashield mounting medium (Vector Labs,
Burlingame, CA).  General DRG immunostaining, which did not include any processing
for myelin component detection, involved explant fixation for 10 minutes at 4°C in 4%
paraformaldehyde/4% sucrose in PBS, pH 7-7.4.  After washing with PBS, a 7 minute
permeablization using PBS-T followed.  After washing with PBS, cultures were blocked
with 10% BSA in PBS for 1 hour at 37°C.  Primary antibodies were then diluted in 2%
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BSA in PBS and incubated for 1-2 hours at 37°C.  Coverslips were washed with PBS;
secondary antibodies, also diluted in 2% BSA in PBS (1:1000), were then added and
incubated for 1 hour at 37°C.  After washing with PBS and a water rinse, coverslips were
mounted using Vectashield mounting medium.  SCs were processed similarly with the
exception of fixation for 20 minutes at room temperature.
Using Plan Neofluar, 40X and 100X, N.A. 1.3, oil and Plan Apochromat, 63X,
N.A. 1.4, oil objectives, images were captured at room temperature with IPLab Spectrum
3.1 (Signal Analytics Corporation, Vienna, VA) software on an upright Axioplan
microscope (Carl Zeiss, Germany).  A Sensys digital camera (Photometrics Limited,
Tucson, AZ) was used.  Images were imported into Adobe Photoshop 4.0 (Adobe
Systems, Inc., San Jose, CA) and adjustments of contrast and brightness were made when
necessary to approximate the original IPLab images.  Further, Adobe Photoshop and
Canvas 5 (Deneba/ACD Systems, Inc., Saanichton, BC) were used to generate multi-
panel composites and final figures.  Quantitative analysis was performed where indicated,
and p-values associated with unpaired Student’s t-tests are reported where appropriate.
Sources of primary antibodies are as follows: anti-α-tubulin – Sigma; anti-
ankyrinB (Chan et al., 1993); anti-ankyrinG (Lambert et al., 1997); anti-βIV spectrin – gift
from Masayuki Komada, Tokyo Institute of Technology, Japan (Komada and Soriano,
2002); anti-EBP50 as described herein (Gatto et al., 2003); anti-ERM(20109W) – gift
from Elizabeth Luna, University of Massachusetts Medical School, Worcester, MA; anti-
ERM and anti-phospho-ezrin(Thr567)/radixin(Thr564)/moesin(Thr558) – Cell Signaling
Technology, Inc., Beverly, MA; anti-MAG – Chemicon International, Temecula, CA;
anti-MBP – Boehringer Mannheim/Roche Diagnostics, Indianapolis, IN; anti-N-cadherin
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- BD Transduction Laboratories, Mississauga, ON, Canada; anti-neurofascin (Lambert et
al., 1997); anti-neurofilament (SMI312) – Sternberger Monoclonals, Inc., Lutherville,
MD; Alexa-Fluor 594 phalloidin – Molecular Probes, Eugene, OR; anti-RhoA – Santa
Cruz Biotechnology, Inc., Santa Cruz, CA; anti-T7 – Novagen, Madison, WI; and anti-
VSVG - Roche Applied Science, Indianapolis, IN.  All secondary antibodies were
purchased from Molecular Probes.
Live Cell Imaging
Technical expertise and useful discussion regarding live cell imaging were
generously provided by Joshua Nordberg and Greenfield Sluder (University of
Massachusetts Medical School, Worcester, MA).  Explants or dispersed SCs were either
grown on 22 mm square coverslips (Carolina Biologicals) or in 30 mm Rose dishes
(World Precision Instruments, Sarasota, FL) and treated as indicated.  Preparations were
then mounted for imaging on a DMIRE 2 inverted microscope (Leica Microsystems,
Allendale, NJ) in a 37°C heated plexiglass environmental chamber.  Image acquisition
using a PL Fluotar, 25X, 0.75 N.A., oil objective and an ORCA ER extended range
cooled CCD camera (Hamamatsu, Bridgewater, NJ) was performed using OpenLab 3.0.9
software (Improvision, Lexington, MA).  Image processing was performed with OpenLab
to adjust contrast when necessary and generate video files.  Further processing to allow
video frame rotation was performed with NIH Image 1.62 (developed at the U.S.
National Institutes of Health and available on the Internet at http://rsb.info.nih.gov/nih-
image/).  For still frame composite generation, individual frames were exported from
OpenLab and imported into Adobe Photoshop.  Final figure preparation and migration
distance measurements were performed using Canvas 5.  Quantitative analysis was
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performed where indicated, and p-values associated with unpaired Student’s t-tests are
reported where appropriate.
Teased Sciatic Nerve Fiber Preparation and Immunostaining
Protocols and extensive discussion regarding teased sciatic nerve fiber
preparations were kindly provided by Steven Scherer (Hospital of the University of
Pennsylvania, Philadelphia, PA) and Peter Shrager (University of Rochester Medical
Center, Rochester, NY).  Sciatic nerves were dissected from appropriately staged,
euthanized Wistar rats and fixed on ice for 30 minutes-2 hours using 4%
paraformaldehyde in PBS (pH 7.4).  Nerves were transferred to PBS and cut, with the
outer perineurial sheath on, into segments approximately 0.5 cm long.  Nerves were then
desheathed by grasping one end and slitting the perineurium with a 30-gauge needle.
Using the fine needle,  segments were subdivided into fascicles of nerve fibers.  Several
small fascicles were transferred to a drop of PBS onto a Vectabond (Vector Labs) or
Cell-Tak (Discovery Labware, Inc.) treated slide and air dried overnight at room
temperature.
Sciatic nerve fibers were permeablized by immersion in -20°C acetone for 10
minutes and then rehydrated with PBS.  Blocking solution (5% goat serum in PBS,
0.02% sodium azide, and 0.1% Triton) was applied for at least 60 minutes at room
temperature.  Fibers were then incubated with primary antibody diluted in the blocking
solution in a humidified chamber for 24 hours at 4°C.  Slides were washed with PBS, and
secondary antibody (diluted 1:200 in blocking solution) was then applied for 60 minutes
at room temperature.  Slides were rinsed with PBS and allowed to air dry.  Using
Vectashield as a mounting medium, slides were coverslipped and sealed for microscopy.
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cDNA Constructs
An EBP50 p3xFLAG-CMV7 cDNA was kindly provided by R. Brian Doctor
(University of Colorado Health Sciences Center, Denver, CO).  A full length EBP50
fragment was generated using this construct as a template via PCR introducing 5’ EcoRI
and 3’ BamHI sites for subcloning.  This fragment was digested as indicated for
introduction into a C2-GFP vector (Clontech, Palo Alto, CA) generating full length
EBP50-GFP.  For the deletion of the ERM-binding domain, the EBP50 fragment was
subcloned into pBTM.  The COOH-terminal 70 amino acids were removed, and EBP50-
70 was liberated from pBTM by EcoRI/BglII treatment.  This fragment was inserted into
C2-GFP generating EBP50-70-GFP.  A third EBP50 variant lacking its two PDZ-binding
domains was generated as follows.  EBP50-GFP was EcoRI/BamHI digested to release
an EBP50 fragment that was subcloned into pBS for site-directed mutagenesis to allow
SacI flanking of PDZ2.  After re-introducing this fragment into pBTM, SacI and
XhoI/SalI treatment removed both PDZ1 and PDZ2.  EcoRI/BamHI treatment then
released this fragment for the generation of EBP50-PDZ1+2-GFP.  VSVG (vesicular
stomatis viral G protein)-tagged wild-type and FERM domain ezrin constructs were
generous gifts of Monique Arpin (Institut Curie, Paris, France), and Michael Czech
(University of Massachusetts Medical School, Worcester, MA) kindly supplied PLCδ-
PH-GFP cDNA.  T7-tagged Kv1.5 constructs were generous gifts of David Fedida
(University of British Columbia, Vancouver, BC, Canada).
EBP50 Antibody
An antibody against EBP50 was raised in rabbits for the following study
(Covance, Denver, PA).  A recombinant EBP50-GST fusion was generated using the
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pET-41a+ vector (Novagen) expressed in bacteria, purified, and used as the immunogen.
For antisera purification, His-tagged EBP50 (generated using pET-28b+ (Novagen)) was
isolated using a Talon kit (Clontech, Palo Alto, CA).  This fusion protein was then
coupled to CNBr-Sepharose (Amersham Pharmacia, Piscataway, NJ) and used as an
antibody trap in column-based, batch purification.  After applying serum to the prepared
column, it was washed sequentially with PBS, PBS/0.5 M NaCl, 2 M urea/0.1 M
glycine/20% triton X-100, and PBS.  Antibody was eluted from the column using 4 M
MgCl2.  Eluted antibody was then dialyzed against PBS, followed by 50% glycerol in
PBS, and stored at -20°C.  Antibody concentration was determined by absorbance
analysis, with an OD of 1.28 at 280 nm approximately equivalent to 1 mg/mL.
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Chapter 3
DRG culture establishment and characterization defining the differential
localization of ankyrinB/ankyrinG in specifc axonal populations
Myelin segment and node of Ranvier formation
Ankyrin expression in early DRG growth cones
AnkyrinB/ankyrinG restriction in pre-myelinated axons based on axonal caliber
Differential ankyrinB/ankyrinG localization in teased sciatic nerve fibers
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Introduction
As we have discussed, the initiation and maintenance of myelination requires
considerable investment from both the myelinating glial cell and the chosen axon.  As
molecular and morphologic alterations are effected at the axonal plasma membrane,
coordinated modifications of the associated cytoskeleton are necessary.  Of significant
importance in myelination are the regulated expression, targeting, and retention of the
ankyrins.  Recall that ankyrins are membrane adaptor proteins that immobilize integral
proteins linking them to the spectrin-based membrane skeleton (reviewed in Bennett and
Chen, 2001; Bennett and Lambert, 1999), including cell adhesion molecules
(Bourrguignon et al., 1995; Davis and Bennett, 1993; Kalomiris and Bourguignon, 1988;
Zhang et al., 1998), ion channels and exchangers (Li et al., 1993; Srinivasan et al., 1988),
and calcium-release channels (Bourguignon and Jin, 1995; Bourguignon et al., 1993),
Specific ankyrin isoforms localize to axonal domains and are required for
appropriate neural functionality.  The most abundant ankyrins present in CNS and PNS
axons include the 440 kDa ankyrinB and the 480/270 kDa ankyrinG.  The 440 kDa
ankyrinB employs similar exon usage as compared to the alternatively spliced 220 kDa
isoform with the additional inclusion of a 220 kDa tail region separating the spectrin-
binding domain and the COOH-terminal region (Chan et al., 1993) (Chapter 1, Fig. 5).
Moreover, the 440 kDa ankyrinB is generally restricted to pre- and unmyelinated axons
(Chan et al., 1993; Kunimoto et al., 1991) where it co-localizes diffusely with the cell
adhesion molecule, L1.  The domain usage in ankyrinG 480 kDa is similar to that of the
440 kDa ankyrinB with the addition of a serine/threonine enriched (35%), o-GlcNAc
glycosylated region (residues 1478-1908) immediately after the spectrin binding domain
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(Chapter 1, Fig. 5) (Kordeli et al., 1995; Zhang and Bennett, 1996).  AnkyrinG 480/270
kDa localizes with the vgsc to axon initial segments and to the nodes of Ranvier with the
vgsc and cell adhesion molecules, neurofascin and NrCAM, in myelinated fibers (Kordeli
et al., 1995; Lambert et al., 1997).
Despite their axonal association and structural and biochemical similarities,
ankyrinB and ankyrinG are not functionally redundant and maintain distinct physiologic
roles.  Examining the phenotypes of ankyrinB and ankyrinG knockout mice provides the
best demonstration of the ankyrins’ non-overlapping roles in neural development and
function.  AnkyrinB null mice display lateral ventricle dilation, loss of L1 from long fiber
tracts in the brain and spinal cord, and severe optic nerve degeneration (Scotland et al.,
1998).  This mutation is lethal in the early neonatal period with resultant death by P21.
Alternatively, a cerebellum-specific deletion of ankyrinG results in viable, fertile animals
with no obvious neurologic defect until P16-17.  This disruption of ankyrinG expression
leads to a progessive ataxia including abnormal gait, tremor, and generally reduced
locomotion (Zhou et al., 1998).  In addition, the localization of vgscs to the initial
segments of granule cell neurons is compromised, and the action potential firing capacity
of the Purkinje neurons is severely impaired, leading to degeneration.
Studies in sciatic nerve and dispersed DRG cultures suggest that ankyrinB and
ankyrinG isoforms are present in the same axons and may be coordinately regulated
during myelination.  AnkyrinB is believed to be down-regulated at the onset of
myelination in a fashion similar to that of its binding partner, L1.  This was initially
observed in optic nerve studies where ankyrinB (and thus L1) was lost upon expression of
the myelin protein, MBP (Bartsch et al., 1989; Chan et al., 1993).  Accordingly, upon
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myelination, ankyrinG becomes redistributed from a continuous localization along the
axon to clusters at sites of nodal development.  This ankyrinG reorganization occurs
concomitantly with its interacting proteins neurofascin, NrCAM, and the vgsc (Chan et
al., 1993; Kordeli et al., 1995; Kunimoto, 1995; Kunimoto et al., 1991; Lambert et al.,
1997).  (Fig. 8)
The data concluding ankyrinB and ankyrinG to be co-localized in pre-
/unmyelinated axon tracts are puzzling (Lambert et al., 1997; Zhang and Bennett, 1998).
While areas of overlapping ankyrinB and ankyrinG immunoreactivity are apparent, there is
no mention or attempt to address the more substantial, mutually exclusive staining
patterns that are also observed.  As this could be of significant physiologic relevance, we
examined ankyrinB and ankyrinG expression in PNS cultures derived from DRG explants
allowing the distinct visualization of individual axons.  Interestingly, ankyrinB and
ankyrinG exhibited differential localizations to specific axonal populations.  This was
evident as early as one day in vitro in early DRG growth cones and persisted over time.
In mature pre-myelinated cultures, a clear correlation between axon caliber and ankyrin
expression, as detected by immunofluorescence, was identified. These observations
indicate that distinct populations of axons emanate from the DRG, and contrary to
previous findings, axons destined for myelination and node formation may express a
distinct complement of peripheral, and by association integral, membrane proteins as
compared to those observed in non-myelinated axons.  These distinguishing features may
play a role in the selection of axons for myelination.
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Figure 8 - Model – Myelination and proposed molecular rearrangements
Several studies suggest coordinate regulation of certain membrane-associated elements
during myelination.  It is proposed that in premyelinated axons, the cytoskeletal
components, ankyrinB and ankyrinG, cell adhesion molecules, L1, NrCAM, and
neurofascin, and vgscs are maintained in a continuous distribution along the axon.  Then,
ankyrinB is down regulated at the onset of myelination in a fashion similar to L1.  In
contrast, upon myelination ankyrinG becomes redistributed and clustered at sites of nodal
development with neurofascin, NrCAM, and vgscs.
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Results
Myelin segment and node of Ranvier formation
DRG explants were established to examine PNS development, in particular to
resolve ankyrin expression patterns in pre-myelinated axons.  This culture system
allowed the distinct visualization of individual axons in association with endogenous glial
cells and could be maintained in a pre-myelinating state by culture condition
manipulation.    Upon the adhesion of the isolated DRGs to the prepared coverslips,
neurite outgrowth proceeded with the elaboration of growth cones, which directed axonal
extension.  This rapid axonal outgrowth provided mito- and motogenic stimuli prompting
SC proliferation and migration along the axons (Chapter 2, Fig. 7 and Video 1).  Once the
length of the axons were fully lined by closely associated SCs, this system allowed for
the precisely controlled induction of myelination upon the addition of serum and
ascorbate to the culture medium (Eldridge et al., 1987).  This was evidenced by the
identification of mature myelin segments, as detected by MBP immunoreactivity after 14
days induction [35 total days in culture/14 days post induction of myelination with serum
and ascorbate (d35/M14)] (Fig. 9).
Sciatic nerve studies have demonstrated that as nodal development ensues, the
formation of mature nodes of Ranvier involves the fusion of paired clusters of nodal
components, which form at the tips of adjacent myelinating SCs in the PNS (Lambert et
al., 1997).  We were able to detect maturing compact, hemi-, binary, and broad nodes,
detected via ankyrinG staining (Figs. 9A, B).  Futher, this explant culture system allowed
visualization of multiple nodal specializations along a substantial length (>500 µm) of an
individual axon (Fig. 9B).
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broad
compact
Figure 9 - Node of Ranvier and myelin segment
formation in DRG explants
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Figure 9 - Node of Ranvier and myelin segment formation in DRG explants
A) AnkyrinG (green) and MBP (red) staining were used to demonstrate nodes of Ranvier
and myelin segments, respectively, after 35 days in culture and 14 days induction with
serum and ascorbate (d35/M14).  Composite images show mature compacting, hemi-, and
broad nodes (arrows), with magnified views shown as insets.  B) AnkyrinG (red) and
MBP (blue) staining demonstrate numerous myelin segments and associated nodes along
one individual axon over a considerable distance (>500 µm).  Arrowheads indicate broad,
binary, and mature, compacting nodes.  Scale bar=10 µm, unless otherwise indicated.
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As has been described, node formation not only includes the clustering of the
cytoskeletal element ankyrinG, but also the axonal cell adhesion molecules, neurofascin
and NrCAM.  In mature myelinated cultures (d67/M46), nodal clusters of neurofascin
were readily identified in co-localization with ankyrinG.  Further, on rare occasion when a
DRG cell body was separated from the explant proper, visualization of the axonal initial
segment, which is also enriched in ankyrinG, was possible (Fig. 10).  In addition, the first
hemi-node indicating the start of the myelinated region of the axon was also visible.  An
associated neurofascin cluster at the distal region of the ankyrinG-stained initial segment
defined its border.
These findings indicate that stages of nodal development described in vivo were
well represented in these in vitro cultures.  As these discrete, well-defined molecular
rearrangements were clearly evident, we were confident then to examine the predicted
regulation and expression of the axonal ankyrins in this system.
Ankyrin expression in early DRG growth cones
We first examined the ankyrinB and ankyrinG distributions in DRG growth cones.
At d1, ankyrin staining revealed that early axons and their associated growth cones were
reactive to both ankyrins, but not to the same extent (Fig. 11).  Individual growth cones
qualitatively more reactive to ankyrinB, ankyrinG, or a combination of both were readily
identified.  These results suggest that both ankyrins may have roles in growth cone
elaboration and neurite extension.  Further, their differential localization may be the first
molecular indication of an inequality and distinguishing feature associated with the axons
originating from the DRG explant.
AnkG Neurofascin MBP Composite
d67/M46
Figure 10 - Node of Ranvier and initial segment
formation in DRG explants
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Figure 10 - Node of Ranvier and initial segment formation in DRG explants
Immunocytochemistry was performed using antibodies against ankyrinG (green),
neurofascin (red), and MBP (blue) in a mature, myelinated culture (d67/M46).  The top
row of panels illustrates the formation of ankyrinG and neurofascin-positive nodal clusters
(arrowheads) adjacent to the distal tips of the myelinating SCs.  The bottom row of panels
demonstrates ankyrinG localization to a DRG axonal initial segment (arrows).  The
neurofascin cluster immediately apposing the ankyrinG initial segment staining indicates
the first nodal region of the myelinated axon.  Scale bar=10 µm.
AnkB AnkG Composite Phase
d1
Figure 11 - AnkyrinB and ankyrinG
present in early DRG growth cones
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Figure 11 - AnkyrinB and ankyrinG present in early DRG growth cones
Explants (d1) were stained with antibodies against ankyrinB (red) and ankyrinG (green).
This revealed different populations of axons extending from the body of the DRG.
Axons and growth cones were qualitatively more reactive to ankyrinB, ankyrinG, or a
combination of the two.  Scale bar=10 µm.
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AnkyrinB/ankyrinG restriction in pre-myelinated axons based on axonal caliber
As variable immunoreactivity to ankyrinB and ankyrinG was detectable as early as
d1 in culture, a time course examining the localizations of these proteins was performed.
Upon the examination of pre-myelinated explants from d5, 8, 14, and 28, the differential
localization of the ankyrins to distinguishable, separate populations of axons was
maintained (Fig. 12).
Quantitative evaluations of the observed differential localization were undertaken
in mature standard cultures.  At d35, pre-myelinated explants still maintained discrete
ankyrin localizations (Fig. 13A).  The equivalent myelination-induced stage (d35/M14)
displayed clear nodal development, mature myelin segment formation, and distinct
ankyrin staining patterns for both ankyrinB and ankyrinG in other pre- and/or non-
myelinated axons.  This was in contrast to previous findings that ankyrin expression was
altered during myelination, with ankyrinB being down-regulated in myelinated axons and
retained in unmyelinated axons while ankyrinG disappeared from unmyelinated axons
(Lambert et al., 1997).
Interestingly, there was a distinct correlation between the ankyrin preferentially
expressed and apparent axonal diameter in mature pre-myelinating explants (d41).
57.6% of the total population of axons was reactive for only ankyrinB, 41.1% for only
ankyrinG, and 1.3% for both.  Further, 94% of the ankyrinB-positive axons range in
caliber from 0.33-0.83 µm, whereas 64% of the ankyrinG-positive axons range from 1-
1.65 µm (Fig. 13B).  In addition, the axonal caliber was considered in terms of only the 1
µm size requirement for PNS myelination.  Of the total axons measuring less than 1 µm
in diameter, 80% were immunoreactive for ankyrinB.  Of the axons greater than or equal
d5
d8
d1
4
d2
8
AnkB AnkG Composite
Figure 12 - AnkyrinB and ankyrinG differentially
localize in pre-myelinated DRG axons
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Figure 12 - AnkyrinB and ankyrinG differentially localize in pre-myelinated DRG axons
A time course of pre-myelinated explants (d 5, 8, 14, and 28) was examined for ankyrin
localization.  The staining patterns define axonal populations that differ in their ankyrinB
(red) and ankyrinG (green) reactivity.  Scale bar=10 µm.
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Figure 13 - Differential ankyrin localization correlates with axonal caliber
As there appeared to be a link between axonal diameter and ankyrin
expression/reactivity, we examined the nature of this correlation.  A) d35 pre-myelinated
or d35/M14 myelinated explants were stained for ankyrinB (red),  ankyrinG (green), and
MBP (blue).  Arrows denote nodes of Ranvier.  Scale bar=10 µm.  B) In a mature pre-
myelinated culture (d41), 151 discretely individual axons were counted.  Presented is a
quantification of the relationship of ankyrin expression (B/G) and axonal diameter.
57.6% of the total population of axons was reactive for only ankyrinB, 41.1% were
reactive for ankyrinG, and 1.3% were reactive for both.  Further, 94% of the ankyrinB-
positive axons range in caliber from 0.33-0.83 µm, whereas 64% of the ankyrinG-positive
axons range from 1-1.65 µm.  C) To examine the ankyrin expression pattern seen in
axons likely to be myelinated, axonal diameters were classed in relation to the 1 µm size
cut-off generally associated with PNS myelination.  Of the total axons measuring less
than 1 µm in diameter (103:151), 80% were immunoreactive for ankyrinB, whereas in
axons greater than or equal to 1 µm (41:151) in diameter, 89% were reactive for
ankyrinG.
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to 1 µm in diameter, 89% were reactive for ankyrinG (Fig. 13C).  These results strongly
suggest a link between the axonal caliber that generally meets the PNS requirement for
myelination and ankyrin expression, as detected by immunofluorescence.  Thus, the
ankyrin profile of an axon may be a distinguishable feature in terms of its predetermined
myelination status.
Differential ankyrinB/ankyrinG localization in teased sciatic nerve fibers
As a considerable disparity was seen as to the ankyrin localization in the in vitro
DRG explant culture system as compared to reported findings in sectioned sciatic nerve
(Lambert et al., 1997), we extended our recent findings to another in vivo alternative.  As
myelination is primarily a post-natal event in the PNS (reviewed in Garbay et al., 2000),
sciatic nerve teased fibers from neonatal animals were examined.  P4 sciatic nerves
revealed variant axonal tracts that stained, in a mutually exclusive manner, for either
ankyrinB or ankyrinG (Fig. 14).  These results suggest that there may indeed be in vivo
physiological relevance to the observed in vitro differential ankyrin localization.
P4 
AnkB AnkG Composite Phase
Figure 14 - Ankyrin localization in teased sciatic nerve fibers
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Figure 14 - Ankyrin localization in teased sciatic nerve fibers
Sciatic nerves were removed from P4 rat pups, fixed, separated, and stained.  Preliminary
results indicate that in pre-myelinated tissue, ankyrinB (red) and ankyrinG (green) are
differentially localized in distinct axonal tracts.  Scale bar=10 µm.
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Discussion
This study demonstrates that the in vitro DRG explant culture system allows
visualization of precise events in PNS myelination.  This system supports the study of
both axonal and SC development.  Myelin segment formation is well represented, and the
organization of the associated nodes of Ranvier is comparable to in vivo findings.
Having established the appropriateness of this system for further PNS myelination-based
studies, predicted myelination-dependent molecular rearrangements were examined and
characterized.
We have exposed the differential localization of ankyrin isoforms in axons of
variable caliber.  Those axons of an appropriate apparent size (>1 µm in diameter) for
myelination were shown to be specifically reactive for ankyrinG, while smaller caliber
axons were more frequently reactive for ankyrinB.  Our results sharply contrast with
previous findings that indicated ankyrinG 480/270 kDa and ankyrinB 440 kDa were co-
expressed together at significant levels prior to myelination and continuously co-
distributed along the length of the axon (Lambert et al., 1997).
The striking difference in the cytoskeletal composition of sub-populations of pre-
myelinating axons in PNS cultures may have significant implications in terms of
inherent, axonal properties.  In particular, the presence of a specialized cytoskeleton may
translate into a distinct repertoire of membrane-associated proteins.  As axonal ankyrin-
binding membrane proteins, such as neurofascin, have shown no in vitro biochemical
discrimination between ankyrinB and ankyrinG isoforms (Davis and Bennett, 1993), our
evidence promotes the concept of wholly restricted ankyrin expression serving to drive
particular membrane protein presentation in the PNS.  Alternatively, the differential
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ankyrin distribution may reflect a previously unknown step in pre-myelinated axonal
commitment.
This qualitative observation requires diligent biochemical confirmation by mRNA
and protein expression analysis.  Also remaining to be determined in a continuation of
this work is whether a coordinated differential membrane composition is associated with
axons of variable caliber and the differential ankyrin expression.  This could lead to the
identification of target molecules that trigger axo-glial recognition cascades either
initiating SC myelination (in association with ankyrinG) or promoting ensheathement and
maintenance of a non-myelinating SC pheontype (in association with ankyrinB).
For example, one proposed mechanism for the functionality of ankyrinB and L1 in
pre-/unmyelinated axons is the stabilization of axon-axon interactions.  As robust inter-
axon adhesion via L1 could promote axonal bundling, this would preclude SC investiture
and prevent myelination by blocking achievement of the requisite 1:1 SC:axon ratio
(reviewed in Bennett and Lambert, 1999).  As a result, the axon-associated SC may
default to a non-myelinating state and simply ensheathe the bundle.  Similarly, it would
be of interest to determine the fasciculated nature of axons specifically expressing
neurofascin and NrCAM, which are likely to be associated with ankyrinG.  Perhaps these
molecules generate comparably weaker adhesions than L1 itself and allow for marginal
disruption of axon-axon engagement by glial cell process extension.  This in turn could
promote axonal segregation by pro-myelinating SCs and enable axo-glial interactions
leading to myelination.
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Chapter 4
Local ERM activation and dynamic growth cones at
Schwann cell tips implicated in efficient node of Ranvier formation
Localization of microvillar components at SC tips
is an early event in the myelin program
Live cell imaging reveals the existence of a novel, dynamic
 “growth cone”-like structure at the tips of myelinating SCs
Local activation of Rho signaling pathway at SC tips gives rise to
 caps and influences node formation
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Introduction
As previously described, myelination is a vertebrate adaptation which involves a
specialized glial cell generating an insulating, multi-lamellar sheath around an associated
axon (reviewed in Arroyo and Scherer, 2000; Scherer and Arroyo, 2002).  This is coupled
with the specific localization of vgscs to gaps in the myelin sheath, known as the nodes of
Ranvier.  As these channels are enriched in this domain at concentrations of minimally
40-fold excess as compared to internodal regions, the electrical requirements to promote
rapid, saltatory conduction of action potentials are met while sparing a concomitant
increase in axonal caliber (Ritchie and Rogart, 1977; Shrager, 1989).
The development of the nodes of Ranvier not only involves substantial
morphological alterations in the myelinating glial cell but is also hallmarked by the
discrete polarization of axonal cell adhesion molecules, cytoskeletal components, and ion
channels, as discussed in Chapter 3.  Upon myelination, the L1 cell adhesion molecule
and the 155 kDa isoform of neurofascin are down-regulated and removed from the axonal
plasma membrane.  Conversely, the 186 kDa isoform of neurofascin and NrCAM become
highly localized to the node in association with ankyrinG and vgscs (Davis et al., 1996;
Kordeli et al., 1995; Lambert et al., 1997; Martini and Schachner, 1986).
The role of axo-glial contacts in promoting vgsc clustering at the node remains
controversial.  As indicated in Chapter 1, vgsc clusters have been observed in the axons
of retinal ganglion cells cultured in the presence of oligodendrocyte conditioned media,
but in the absence of cellular contact (Kaplan et al., 1997).  Similarly, observations of
vgsc clusters in amyelinated regions of axons from the dystrophic mouse (Deerinck et al.,
1997) support the hypothesis that vgsc clustering is independent of glial cell contacts.
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However, in vitro myelinating culture studies have shown a requirement for SC contacts
in mediating axonal vgsc clustering (Ching et al., 1999).  This is supported by in vivo
observations, which have shown vgscs and other nodal proteins cluster in close proximity
to MAG-positive SC processes during myelination of the sciatic nerve (Lambert et al.,
1997; Vabnick et al., 1996).  Mechanisms underlying these apparently conflicting lines of
evidence remain to be determined.
In the mature PNS, axo-glial contacts at the nodes of Ranvier are established by
SC microvilli (Ichimura and Ellisman, 1991), which are characterized by expression of F-
actin (Trapp et al., 1989), ERMs, and EBP50 (Melendez-Vasquez et al., 2001; Scherer et
al., 2001).  To investigate a potential role for these microvilli in node formation, we have
studied their formation in myelinating DRG explant cultures.  We have observed that
myelinating SCs polarize microvillar components to novel structures at their distal tips
(that we have termed caps) in response to signals that induce myelin formation.  These
caps are enriched in microvillar components including EBP50, actin, and activated
phospho-ERMs.  Using EBP50-GFP as a probe in live cell imaging experiments, we
observed that SC caps are highly dynamic with behavior reminiscent of an axonal growth
cone.  We also localized the small GTPase RhoA to the SC cap and found that activation
of the Rho pathway was linked to cap formation.  Together, these results suggest a
localized Rho-mediated activation of ERM proteins at the SC cap.  Further, the
uncoupling of cap formation and myelination interfered with efficient node formation,
implicating the SC as having a direct role in establishment of the nodes of Ranvier.
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Results
Localization of microvillar components at SC tips is an early event in the myelin program
In this study, myelinating DRG explants were used to examine SC differentiation
and formation of the nodes of Ranvier.  This system allowed for the controlled induction
of myelination upon the addition of serum and ascorbate to the culture media.  This
enabled the consistent generation of substantially myelinated cultures, as indicated by
MBP staining to reveal compacted myelin (Fig. 15B). Occasionally, small numbers of
segments were also observed in cultures maintained in standard feed (Fig. 15A).  When
present, these segments were aberrantly short with irregular morphology and inconsistent
nodal association.
To follow the evolution of nodal SC microvilli in our myelinating cultures, we
generated an antibody to EBP50.  EBP50 was observed to localize to the SC nodal collar
of microvilli in mature myelinated (d47/M26), confirming in vivo observations in mature
sciatic nerve (Melendez-Vasquez et al., 2001).  Staining at the nodal regions illustrated
EBP50 encompassing ankyrinG, which is known to localize to the electron dense
undercoating at the nodal axolemma (Kordeli et al., 1990) (Fig. 15C-G, supplemental
material Fig15video2).
EBP50 polarization in less differentiated cultures was then examined.  MAG,
which is expressed abaxonally by myelinating SCs after approximately 1.5 wraps around
its associated axon (Martini and Schachner, 1986; 1988), was used to visualize earlier
stages of myelination.  After 5-6 days of induction, EBP50 localized to both heminodal
and binary intermediates adjacent to MAG-positive SCs (Fig. 15M) and in close
proximity to axonal clusters of βIV-spectrin (Fig. 15J), a second marker for the nodal,
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Figure 15 - EBP50/ERM localization to early and mature nodes in myelinating DRG
explant cultures
Myelinated and comparable control cultures were stained for MBP to show mature
myelin (A-ST:d47, B-MY:d47/M26).  EBP50/ankyrinG/MBP triple labeling revealed
nodal specializations (C-E).  Note SC microvillar EBP50 staining encompassed axonal
ankyrinG (F).  See also Fig15video2-node.mov.  Less differentiated cultures (M5/6) were
stained with EBP50 (I, L) and either βIV-spectrin (axonal marker) (H) or MAG (early
myelin marker) (K).  EBP50 was clearly present at early hemi- (arrowheads) and binary
(arrows) nodes (M, J).  Scale bar=10 µm, except where indicated.
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axonal, membrane-associated cytoskeleton (Berghs et al., 2000; Komada and Soriano,
2002).  These results indicate a distinct localization of microvillar components, if not
microvilli proper, at mature and developing nodes.
The three ERM proteins (ezrin, radixin, and moesin) are present in SC microvilli
(Melendez-Vasquez et al., 2001; Scherer et al., 2001).  Hence, we utilized a pan-ERM
antibody in conjunction with our EBP50 antibody to examine microvillar organization in
developing SCs.  After 6 days in vitro, EBP50 and ERM staining revealed numerous
microvilli (Fig. 16A-B) covering the surface of migrating glial cells.  Mature SCs,
characterized by a bipolar phenotype (Jessen et al., 1994), also exhibited numerous
microvilli decorating their length (Fig. 16C).
Cultures were then supplemented with serum (15%) and ascorbate (50 µg/mL) to
promote myelination (Eldridge et al., 1987), and a dramatic reorganization of the SC
microvilli was seen.  Upon induction (d27/M6), EBP50 staining became concentrated at
the distal tips of the elongated SCs (Fig. 16G), which was not observed in equivalent
control cultures (Fig. 16E).  Notable variations in tip morphology and EBP50 localization
were also observed suggesting a dynamic component involved in cap formation (Fig. 16I-
K).
Live cell imaging reveals the existence of a novel, dynamic “growth cone”-like structure
at the tips of myelinating SCs
To visualize the dynamics of cap formation in live cells, an EBP50-GFP fusion
construct was used.  When transfected into myelinating DRG cultures, this construct was
observed to localize to cap structures at SC tips (Fig. 17A).  Moreover, this localization
required the ERM binding site of EBP50 (data not shown, addressed fully in Chapter 5).
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Figure 16 - EBP50/ERM localization in pre-myelinating/induced DRG explant cultures
changes from cell surface microvilli to a focal concentration at the SC tip
After 6 days in vitro, cultures were stained for EBP50 (A) and ERM (20109W) (B).  Note
the numerous cell surface microvilli present on migrating SCs.  After 18 days, cultures
were stained for EBP50 (C) and neurofilament (D).  Bipolar SCs displayed microvilli
along their length.  Matched standard cultures (d27) and cultures induced to myelinate
with serum and ascorbate (d27/M6) were stained for EBP50 (E, G) and neurofilament (F,
H).  There was discrete localization of EBP50 to SC tips in the induced cultures.  These
EBP50-positive tips were also found with varying morphologies (I-K).  Scale bar=10 µm.
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Figure 17 - Dynamic EBP50/ERM-positive SC distal tips
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Figure 17 - Dynamic EBP50/ERM-positive SC distal tips
Cultures were transfected after 1 day of induction.  After 5 days of transfection, EBP50-
GFP (A) was seen to co-localize with endogenous phospho-ERM staining at SC tips (B).
These transfected cultures were then examined via time-lapse microscopy.  SCs in
standard cultures (d29/t7) (C-F) showed no specific localization of EBP50-GFP at their
tips (arrows).  See also Fig17video3-EB-ST.mov and Fig17video4-EB-tip-ST.mov.  SCs
in myelinating cultures (d29/M6/t5) (G-J) had dynamic, remodeling EBP50-GFP-positive
tips (arrowheads).  See also Fig17video5-EB-MY.mov and Fig17video6-EB-tip-
MY.mov.  Further, deconvolution microscopy revealed EBP50-GFP as having a punctate
distribution (K-O).  Scale bar=10 µm.
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As the binding site for EBP50 is masked on inactive ERM molecules (Gary and
Bretscher, 1995; Matsui et al., 1998), these results suggest that localization of EBP50-
GFP to SC caps reflects the local activation of ERM molecules at these sites.  In support
of this idea, EBP50-GFP was found to co-localize with COOH-terminal phospho-ERM
staining (Fig. 17B), indicative of active forms of these proteins (Reczek et al., 1997;
Reczek and Bretscher, 1998).
Time lapse imaging of explants harboring EBP50-GFP transfected SCs
demonstrated the dynamics of the EBP50-positive tips.  Cultures sustained in standard
feed [29 total days in culture/7 days post-transfection (d29/t7)] maintained EBP50-GFP
diffusely throughout the cytoplasm without any distinctive localization (Fig. 17C-F,
supplemental material Fig17video3-4).  Notably, these EBP50-GFP transfected SCs
appear smoother than comparable EBP50-stained SCs under standard conditions (Fig.
16C).  Due to the lower magnifications used for time lapse imaging and over-expression
of the construct, fluorescence from the cell body overwhelms the signal contributed from
the fine microvilli along the SC length.  However, in cultures supplemented to promote
myelination (d27/M6/t5), EBP50-GFP became highly localized to SC tips and displayed
active remodeling (Fig. 17G-J, supplemental material Fig17video5-6).  Deconvolution
microscopy demonstrated EBP50-GFP in a punctate distribution throughout the cell body
as well as concentrating at SC tips (Fig. 17K-O).
To determine whether the GFP-remodeling reflected actual changes in the
morphology of the SC tip, we studied acutely dispersed SC preparations.  These isolated
SCs were derived from P2 sciatic nerve and were cultured in the absence of in vitro
axonal contact.  This allowed for visualization of individual cells that was not possible
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without transfection in explants due to the culture complexity.  As observed in explant
SCs, isolated bipolar cells displayed discrete tips enriched in microvillar components,
such as EBP50 and actin (Fig. 18A-H).  Further, the tip-localizing ERMs were activated
versions of these proteins (Fig. 18I-L), whereas non-phosphorylated ERMs were
diffusely present in the SC body and processes (Fig. 18M-P).  Concentrations of RhoA
were also observed at the SC tips (Fig. 18Q-T).  Specifically, 79.1±1.7% (data presented
as mean±SEM) of SC tips that were positively immunostained for either EBP50 or
phospho-ERM also displayed accumulations of RhoA.
As explant studies demonstrated the specific rearrangement of EBP50 at SC tips,
isolated SCs were then imaged to examine the general nature of the cells’ distal region.
SC tips were reminiscent of actively remodeling axonal growth cones.  Isolated cells
revealed significant detail including the elaboration of lamellipodia and extension of
fillopodia (Fig. 19).  We hypothesize that these SC distal tips may then serve as novel
glial growth cone-type structures that enable axonal recognition and segregation as well
as the establishment of early nodes in the process of myelination.
Local activation of Rho signaling pathway at SC tips gives rise to caps and influences
node formation
SC caps were observed to form in response to culture conditions that promoted
myelination in DRG explant cultures, namely the addition of serum and ascorbate.  To
determine which of these components stimulated cap formation, cultures were
independently supplemented with either serum or ascorbate.  It was observed that the
presence of serum was required for cap formation in studies of endogenous EBP50
staining (Fig. 20A-D).  Quantitative analysis of this phenomenon using EBP50-GFP
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Figure 18 - EBP50, actin, activated ERMs, and RhoA localize to SC tips
Isolated SCs were stained to identify other proteins residing at the tips.  EBP50 was
found at the tip of α-tubulin containing SC processes (A-C).  Actin co-localized with
EBP50 at the SC tip (E-G), as did activated, phospho-ERMs  (I-K).  Pan-ERM antibody
(Cell Signaling Technology, Inc.) staining revealed ERMs generally present at the SC
tips.  However, this staining was less concentrated at these sites than is observed with
activated ERMs and more diffusely localized throughout the SC body and processes (M-
O).  In addition, the small GTPase RhoA localized generally to the SC distal tip in close
proximity to EBP50 (Q-S).  Quantitatively, 79.1±1.7% of EBP50 or phospho-ERM
reactive SC tips displayed distal RhoA accumulations (N=4 independent experiments
with an average of 98.5±10.9 cells counted).  Scale bar=10 µm.
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Figure 19 - SC tips display novel growth cone-like behavior
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Figure 19 - SC tips display novel growth cone-like behavior
Isolated SCs were studied using time-lapse live cell imaging.  SC tips (arrow) displayed
dynamic, active remodeling similar to that seen in an axonal growth cone (B-M).
Specifically, filopodial extensions (E, F) and lamellipodial elaborations (G-M) were
evident.  Scale bar=10 µm.
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Figure 20 - Cap formation is dependent upon serum and can be promoted via Rho-
stimulation
At d21, cultures were supplemented with either serum or ascorbate alone, maintained for
6 days (d27/x6), and then stained for EBP50 (A, C) and neurofilament (B, D).  Cap
formation was found to be serum-dependent.  This was also shown with DRG cultures
transfected with EBP50-GFP.  At d27/x6/t5, various culture conditions were examined as
indicated with panels I-L showing higher magnifications of E-H.  EBP50-GFP was found
at SC cap structures (arrows) in complete myelin feed (serum+ascorbate) (F, J) and
cultures supplemented with serum only (G, K).  Cultures were also treated with LPA (1
µM) to simulate serum stimulation of Rho pathways.  Quantification revealed the
presence of serum induced a 5-6 fold increase in the number of caps as compared to
standard feed or ascorbate alone.  LPA was able to compensate for serum in both the
presence and absence of ascorbate.  The Rho-kinase inhibitor Y-27632 (Y 2-20 µM, as
indicated) was able to fully block cap formation in the presence of LPA but not complete
myelin feed.  N=number of coverslips analyzed from at least two independent cultures
each having 2 DRGs per coverslip.  An average of 423±41 cells per coverslip were
counted.  Scale bar=10 µm.
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transfection experiments (Fig. 20E-L) revealed that the presence of serum induced a 5- to
6-fold increase in the number of EBP50-positve caps as compared to ascorbate alone.
Further, ascorbate alone was as ineffective as standard feed in inducing cap formation
[2.8±0.8% vs. 2.3±0.6%, respectively, p=0.6305], whereas serum alone produced similar
results as compared to complete myelin feed (serum+ascorbate) in promoting cap
formation [11.6±0.7% vs. 14.2±1.1%, respectively, p=0.0903] (Fig. 20).
ERM activation has been demonstrated to be downstream of Rho activity (Matsui
et al., 1998; Shaw et al., 1998; Yonemura et al., 2002).  Our observations, including the
effects of serum and Rho localization, implicate a local activation of the Rho pathway in
cap formation.  We therefore used the serum phospholipid lysophosphatidic acid (LPA)
to determine whether or not RhoA pathway activation affected cap formation.  LPA has
been shown to stimulate Rho-dependent pathways influencing cytoskeletal architecture in
various cell types, including SCs (Weiner et al., 2001).  Cultures were treated with 1 µM
LPA or 1 µM LPA+50 µg/mL ascorbate.  It was observed that LPA was able to
compensate for an omission of whole serum from the culture medium.  LPA alone
generated 9.9±0.7% transfected SCs polarizing EBP50-GFP to cap structures, while
LPA+ascorbate resulted in 11.7±1.6% (Fig. 20).
Downstream effectors implicated in Rho signaling include the Rho-associated
kinases (ROCKs), p140mDia, and the phosphatidyl-inositol 4-phosphate 5-kinase (PI 4,5
kinase) (reviewed in Kaibuchi, 1999).  To examine the contribution of the Rho kinases in
LPA-induced cap formation, cultures were treated with Y-27632, a pyridine derivative
which functions as a specific inhibitor of p160ROCK (ROCKI) and ROCKII (Ishizaki et
al., 2000; Uehata et al., 1997).  Y-27632 treatment (2 µM) reduced the capacity of LPA
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to facilitate cap formation to a level similar to that of control cultures maintained in
standard feed (p=0.4379).  Surprisingly, cap formation in cultures maintained in complete
myelin feed was reduced by only 35% following Y-27632 treatment (20 µM) (Fig. 20).
These results demonstrate that LPA can substitute for serum in cap formation and does so
via a Rho-kinase stimulated pathway.  However, the inability of 2-20 µM Y-27632 to
fully inhibit cap formation in the presence of serum suggests that other pathways may
also be operating in this process.
Polarization of microvillar components appears to be an early event in
myelination.  As microvilli are observed to form contacts with developing nodes of
Ranvier, we examined whether SC cap formation was linked to the clustering of proteins
at the nodal membrane.  Cultures were induced to myelinate under various conditions,
and myelin segments with associated nodal clusters of ankyrinG were detected by triple
staining with antibodies to MBP, ankyrinG and phospho-ERM (Fig. 21A-F).  65.6+3.6%
of myelin segments exhibited associated ankyrinG staining at both ends of the segment in
cultures treated with both serum and ascorbate.  Cultures treated with ascorbate only
exhibited 47.2+3.6% of myelin segments with associated ankyrinG staining and a 4-fold
increase in the number of myelin segments that showed no associated ankyrinG staining
(17.4+2.8% of myelin segments vs. 4.1+0.8% of segments in cultures treated with serum
and ascorbate, p=0.0006).  In contrast with previous reports (Eldridge et al., 1987), the
average number of myelin segments formed in each culture appeared independent of
serum.  However, the addition of serum did result in segments of greater average length
than those observed in ascorbate alone (Fig. 21A, D).  No clusters of ankyrinG staining
were observed without accompanying phospho-ERM staining (Fig. 21D-F).
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Figure 21 - Efficient node formation is linked to cap formation
Cultures maintained with either ascorbate alone or complete myelin feed were stained for
MBP, ankyrinG, and phospho-ERM.  Myelin segments were identified and each nodal
region associated was examined (A, D) (closed arrowhead – left-most tip of segment,
open arrowhead – right-most tip of segment).  Each segment was classified based on the
presence (E-F) or absence (B-C) of associated nodes.  It was observed that serum
stimulation in complete myelin feed resulted in a mean of 1.4 times more segments
having 2 nodes, whereas ascorbate alone produced a 4-fold increase in the mean number
of segments formed in the absence of nodes.  In addition, cultures were treated with
LPA+ascorbate.  While LPA was able to moderately compensate for serum, there was a
2-fold increase in the mean number of segments without nodes.  Finally, cultures were
treated with complete myelin feed+Y-27632.  Here, a 3-fold increase in the mean number
of segments without nodes and a 30% decrease in segments with 2 nodes were observed.
N=number of coverslips analyzed from at least two independent cultures each having 2
DRGs per coverslip.  An average of 297±41 (mean±SEM) segments per coverslip were
counted.  Scale bar=10 µm.
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Cultures were also treated with LPA+ascorbate and complete myelin feed
containing Y-27632 to determine their effects on node formation.  LPA+ascorbate
produced moderately similar results as compared to complete myelin feed (8.7% nodal
absence, 54.7% nodal presence).  Although, there was a 2-fold increase in the MBP-
positive segments formed in the absence of nodes (p=0.0253), as compared to complete
myelin feed.  This indicates that while LPA can substitute for serum in these cultures, it is
not quite as efficient in promoting node formation.  The addition of Y-27632 to cultures
maintained in myelin feed produced considerable effects on the node-segment association
(Fig. 21).  Here, a 3-fold increase in the mean number of segments without nodes
(p=0.0011) and a 30% decrease in segments with 2 nodes (p=0.0266) were observed, as
compared to myelin feed alone.  Together these experiments demonstrate that culture
conditions promoting formation of SC caps lead to enhanced node formation.  In further
support of this correlation, quantification of cultures at d32/M11 revealed an 84.1%
reduction in the number of caps present in areas enriched in myelin segments (3.9E-
05±7.2E-06 caps per µm2), as compared to regions devoid of segments (2.5E-04±1.1E-05
caps per µm2).  This indicates that within a given myelinating culture, a decrease in the
mean number of caps in areas of segment formation ensues, suggesting that many cap-
forming cells indeed proceed to form myelin segments.
As these results strongly suggest a role for SC microvilli in node formation, a
causative relationship has yet to be established.  Clarification of this point was addressed
by attempted disruption of ERM functionality and, potentially, microvillar structural
integrity.  This was achieved by employing the available dominant-negative (DN)
variants of one microvillar cap-localizing protein, ezrin.  SCs were transfected with either
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wild type (WT) or DN-ezrin constructs harboring a VSVG-tag for detection (M. Arpin,
Instit Curie, Paris, France).  After inducing myelination in these cultures, formation of
nodes associated with myelin-forming transfected cells was examined (d42/M21/t20).
Transfected, myelin-forming SCs were detected, although their occurrence was extremely
rare.  It appeared that the WT-ezrin construct does not have an effect on node formation
as defined by the axonal clustering of ankyrinG.  Moreover, the DN-ezrin construct
appears to abolish node formation, perhaps via interference with the appropriate
formation and functionality of the SC microvilli (Fig. 22).  These initial results are
encouraging, however, enough of these cells have yet to be identified to present
meaningful quantitative data.
Supplemental Material
An animated 3-dimensional rendering of a deconvolved node of Ranvier is available
showing the relationship between EBP50 and ankyrinG staining (Fig15video2).  In
addition, the original time-lapse videos from which the still images presented in Figure
17 were taken are available for viewing as supplemental material.  Fig17video3 contains
time-lapse fluorescence microscopy of an EBP50-GFP transfected SC maintained in
standard feed.  Fig17video4 specifically shows the distal tip of this cell.  Fig17video5
shows time-lapse fluorescence microscopy of an EBP50-GFP transfected SC after the
induction of myelination using serum and ascorbate.  Fig17video6 shows the remodeling
EBP50-enriched tip of this cell.  Supplemental material is available on the provided CD,
and more detailed video descriptions can be found in Appendix II.
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Figure 22 - ERM/microvilli disruption leads to impaired node formation
With efficient node formation correlatively linked to cap formation, direct microvillar
disruption was attempted.  SCs were transfected with either VSVG-tagged WT- or DN-
ezrin (red) constructs and assessed for myelination and node formation (d42/M21/t20).
WT-ezrin had no adverse effects on myelination or node formation, as detected by MBP
(blue) and ankyrinG (green) staining, respectively.  DN-ezrin transfected SCs were also
able to generate compact myelin, but did not appropriately cluster ankyrinG, indicating a
failure in node formation.  Scale bar=10 µm.
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Discussion
In this study, we have examined the development of SC microvilli during
myelination in an attempt to understand their potential role in formation of the nodes of
Ranvier.  We have observed that SCs in DRG explants polarize microvillar components
to their distal tips in response to in vitro signals involved in myelin formation,
particularly serum addition.  We have found that these differentiated SC tips (termed
caps) are highly dynamic, growth cone-like structures that result from local activation of
ERM proteins downstream of Rho signaling.  Finally, we have demonstrated that
conditions favoring the formation of SC caps are associated with efficient clustering of
membrane proteins at developing nodes of Ranvier.
These observations are summarized in the model shown in figure 23.  The initial
stages of culture establishment include the migration of pre-myelinating SCs along the
radially extended axons emanating from the DRG.  These cells appear to be aggressively
motile with numerous cell surface microvilli.  As the cultures develop, SCs assume their
characteristic bipolar, myelinating phenotype with microvilli decorating their length.
However, treatment of these cultures with serum and ascorbate (particularly serum)
results in a reorganization of microvillar components into SC caps.  Finally, SCs proceed
to form myelin sheaths coupled with the clustering of proteins at the nodes of Ranvier.
These results demonstrate a correlative association between the polarization of
microvillar components to SC caps and the clustering of ankyrinG, supporting a role for
SC microvilli in node formation.  Dynamic remodeling of the SC tip associated with cap
formation may be important to the efficient clustering of nodal membrane proteins.
Hence, nodes might be formed at much slower rates, if at all, in cultures lacking serum
Migration of pre-myelinating
phenotype
Morphogenesis of myelinating
phenotype
SC elongation and "cap"
formation
Myelination and early node
formation
Addition of serum and ascorbate
Figure 23 – Model - SC progression
toward myelination in DRG explant culture system
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Figure 23 – Model - SC progression toward myelination in DRG explant culture system
Highly motile, pre-myelinating SCs migrate along axons extending from the DRG.
These SCs harbor numerous cell surface microvilli (shown in red).  Morphogenesis of the
SC myelinating phenotype takes place with SCs becoming more longitudinally oriented
and axon-aligned while retaining many cell surface microvilli.  Upon induction, typically
using serum and ascorbate, Rho stimulation then leads to the formation of dynamic SC
cap structures specifically enriched in activated ERM proteins and other microvillar
components (again shown in red).  Elaboration of the myelin membrane (shown in blue)
follows with the clustering of axonal components associated with the formation of early
nodes (shown in green).
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where tip dynamics are greatly reduced.  Alternatively, the dynamic formation of SC caps
and the clustering of ankyrinG may not be functionally coupled.  In this case, serum
would be exerting independent effects on these two processes in myelinating cultures.
With promising initial findings, as described herein, we are further testing this idea by
directly disrupting ERM function and microvilli formation while observing the effects on
nodal protein clustering.
SC caps exhibit morphological and dynamic similarities to axonal growth cones.
ERM proteins are also observed in axonal growth cones and their activity appears critical
to growth cone function (Paglini et al., 1998).  SC caps may also have functional
similarities to growth cones, potentially playing a role in axon recognition and
segregation during early myelination as well as node formation at later stages.  Of
importance would be the identification of SC cap proteins that might participate in these
processes.  These proteins could well be ERM binding proteins such as CD44, which has
been implicated in SC-axon adhesion and neuregulin signaling (Sherman et al., 2000).  At
the node, the cell adhesion molecules neurofascin and NrCAM have been proposed as
candidate proteins for the 40-80 nm filaments observed by electron microscopy to link
SC microvilli to the nodal membrane (Ichimura and Ellisman, 1991).  Perturbing the
function of these proteins has been shown to inhibit the clustering of nodal membrane
proteins (Lustig et al., 2001).  However, potential complementary microvillar receptors
for these molecules facilitating SC-axon adhesion remain unknown.
Our data indicate that the addition of serum to DRG explants effects localized
changes at SC tips.  This might result from concentrations of RhoA that we have
observed at the SC tips and/or a potential enrichment of guanine nucleotide exchange
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factors (GEFs) or guanosine diphosphate (GDP) dissociation factors at these sites.  Given
the known effects of Rho on the actin cytoskeleton, it is highly likely that Rho activation
at the tip accounts for the dynamic nature of these structures in the presence of serum.  As
active ERM proteins interact with RhoGDI (GDP dissociation inhibitor) (Takahashi et
al., 1997), it is also likely that ERM activation at the tip will further enhance the
formation of active Rho molecules.
As well as local activation of molecules at SC tips, serum may also enhance the
movement of vesicle-associated proteins to the tip.  For example, exogenous EBP50-GFP
is localized to a motile population of punctae in transfected SCs.  We have observed that
serum causes dramatic changes in SC length and produces significantly longer myelin
segments than those formed under serum-free conditions.  These findings suggest the
potential for functional interdependencies between cap formation, SC elongation and
segment length, and effective clustering of nodal membrane proteins.
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Chapter 5
Asymmetric ERM activation and EBP50 recruitment are
required in directed motility of mature Schwann cells
Asymmetric process retraction generates a novel class of
functional, motile, unipolar SCs
Asymmetric ERM activation and EBP50 localization
are associated with SC process retraction and migration
ERM proteins are required for appropriate SC motility and polarity maintenance
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Introduction
Schwann cells (SCs) are the myelinating glial cell type in the PNS.  The
generation of their specialized, multi-lamellar myelin membrane involves axon-glial cell
engagement and discrete domain establishment.  Distinct morphologic changes and
molecular reorganizations in axonal and glial cell membranes are required, and SC
motility is crucial to the terminal differentiation of these cells.  Mature SCs must infiltrate
nerve bundles, segregate individual axons, and attain proper positioning while
establishing the correct 1:1 SC:axon relationship prior to the onset of myelination
(Chapter 1, Fig. 4) (reviewed in Arroyo and Scherer, 2000; Mirsky and Jessen, 1999;
Salzer, 2003).
Several effectors of SC migration have been studied to date.  β-neuregulin
enhances SC motility via the MAPK pathway by up to 84% in wound healing assays
(Meintanis et al., 2001), and another neuregulin family member, GGF2, promotes a 63%
increase in early DRG explants (Mahanthappa et al., 1996).  Further, IGF-1 induces a 2-
fold increase in SC motility via PI3 kinase (Cheng et al., 2000).  Other reports indicate
heightened gross SC motility in response to nerve damage (Cheng and Zochodne, 2002).
While these studies demonstrate several key pathways involved in generalized SC
motility, they do not address the highly specialized motility unique to mature SCs in
axonal contact at the onset of myelination.  As SCs mature, they attain their hallmark
bipolar phenotype and undertake environmentally cued, directed migration along axons.
Their bipolarity then presents a challenge in mediating the signal integration necessary to
generate a polarized motility response.  As we have begun to define the dynamic nature
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of the SC tip, we focused on examining the axon-associated modality of migration
employed by these cells.
Solving this puzzle may require the identification of differentially localizing
and/or activating proteins that could play a role in motility initiation.  We have recently
demonstrated that SCs specifically polarize microvillar components to their process tips
in response to signals that potentially activate the Rho pathway (Gatto et al., 2003).
Using fluorescence time-lapse microscopy of transfected SCs within myelinating DRG
explants, we now describe asymmetric ERM activation at SC process tips in association
with the cycling of these cells between stationary, bipolar and motile, unipolar
phenotypes.  As ERM proteins have been implicated in mediating fibroblast cell shape
(Amieva et al., 1999; Lamb et al., 1997), epithelial cell motility (Crepaldi et al., 1997),
and neuronal growth cone morphology, motility, and process stability (Castelo and Jay,
1999; Paglini et al., 1998), these proteins and their specific localizations may be essential
to SC plasticity and the resultant motile responses.
Activated ERMs, characterized by COOH-terminal phosphorylation (Matsui et
al., 1998), with their upstream activator phosphatidylinositol (4,5)-bisphosphate (PIP2)
(Hirao et al., 1996; Yonemura et al., 2002), and their downstream binding partner EBP50
(Reczek et al., 1997), asymmetrically concentrate at the tip of the retracting SC process
and become enriched at the rear of the migrating unipolar cell.  These unipolar SCs then
migrate in a nucleokinetic fashion similar to that described for neurons.  Over-expression
of EBP50 enhances this unipolar migration suggesting a novel role for the adaptor protein
in cell motility.  Finally, perturbations of ERM function severely inhibit SC process
dynamics and result in an impaired, multipolar phenotype.
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The SC neuron-like motility identified in this study suggests a major role for
ERMs and associated proteins at the rear of the cell during nucleotaxic migration.  This
novel study of the motility of bipolar SCs within myelinating DRG explants provides an
important step in understanding the dynamic nature of myelination and SC responses to
peripheral nerve trauma.
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Results
Asymmetric process retraction generates a novel class of functional, motile, unipolar SCs
To assess polarity and motility in a highly polarized cell type, we examined
mature SCs, which assume distinctive bi- or tripolar morphologies (Jessen et al., 1994;
Mirsky and Jessen, 1999).  Specifically, we utilized the DRG explant system to examine
these SC properties upon the initiation of myelination.  DRGs were transfected with GFP
to demarcate individual SCs and observed 6 days post-induction/5 days post-transfection
(M6/t5).  Two discrete morphologic phenotypes were detected (Fig. 24A).  Typical
bipolar SCs were the most prevalent (69.9±0.9%).  However, novel, distinct, unipolar
SCs were also common (17.1±0.6%).  These unipolar cells persist in the induced cultures
over time, albeit at a reduced level (M6 - 17.1±0.6% vs. M14 - 6.8±2.8%).  Further,
staining for the early myelin marker MAG demonstrated both bi- and unipolar
myelinating SCs (Fig. 24B).  These results suggest that unipolar SCs may have a
functional role in early stages of myelination.
To examine the potential interrelationship of these bi- and unipolar SCs, time-
lapse imaging of GFP-transfected cells was performed.  This revealed that the atypical,
unipolar modality is generated by the specific retraction of one SC process (Fig. 25A,
supplemental material Fig25Avideo7).  Further, the unipolar morphology was a
characteristic migratory phenotype displayed after the induction of myelination with
67.8±5.9% of unipolar SCs actively migrating (Fig. 25B, supplemental material
Fig25Bvideo8).  This indicates that a substantial portion of unipolar SCs is engaged in
directed motility, of which a sub-population may be involved in myelination.
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Figure 24 - Functional bi- and unipolar SCs
present in myelinating DRG explants
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Figure 24 - Functional bi- and unipolar SCs present in myelinating DRG explants
A) After 6 days induction/5 days transfection (M6/t5), GFP-positive SCs display two
discrete morphologic phenotypes  [bipolar - 69.9±0.9% (left), unipolar - 17.1±0.6%
(right)].  These results represent quantification of eight independent experiments wherein
an average of 500±65 cells were counted.  B) MAG staining, 6 days post-induction,
reveals bi- and unipolar myelinating SCs.  Scale bar=10 µm.
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Figure 25 - Process retraction generates motile, unipolar SCs
A) After transfection as described, GFP-transfected SCs were time-lapse imaged with
acquisition every 5 minutes over a period of 10 hours.  The generation of unipolar SCs
results from specific process retraction.  These still images illustrate this process over an
elapsed 90 minutes.  See also Fig25Avideo7-GFP-PR.mov.  B) These unipolar SCs then
displayed neuron-like, nucleokinetic, migratory activity.  Upon completed process
retraction toward the SC body, somal translocation occurs.  Still images presented span
an elapsed 545 minutes.  See also Fig25Bvideo8-GFP-MIG.mov.  C) SCs are able to
cycle through polarity states.  This morphologic plasticity is depicted in the still frames
presented spanning an elapsed 120 minutes.  See also Fig25Cvideo9-GFP-cycle.mov.
Arrows indicate the directionality of process retraction or migration.  Scale bar=10 µm.
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The motility displayed by these unipolar cells is similar to the nucleokinetic,
somally translocating migratory patterns seen in neurons (Nadarajah et al., 2003;
Nadarajah and Parnavelas, 2002).  In addition, this polarity shift is readily reversible via
process extension to re-establish bipolarity (Fig. 25C, supplemental material
Fig25Cvideo9).  Thus, mature SCs have an intrinsic, morphologic plasticity, which
enables cycling between uni- and bipolar as dictated by encountered cues.
Asymmetric ERM activation and EBP50 localization are associated with SC process
retraction and migration
We have previously localized the microvillar components EBP50 and activated,
phospho-ERMs (pERMs) to the distal tips of mature SCs in structures we termed SC
caps.  It was proposed that these caps represent a region pre-disposed and primed to form
axo-glial contacts via SC microvilli (Gatto et al., 2003).  To determine if there was a
discernable role for these components in earlier stages of SC positioning, we examined
the endogenous localization of these proteins in apparently cycling SCs.  In GFP
transfected SCs, it was frequently observed that both EBP50 and pERM were
asymmetrically distributed.  In bipolar SCs, the localization was specific to one distal tip
that often was associated with an extended, filopodial structure.  By contrast, in unipolar
SCs, EBP50 and pERM localized to the rear, trailing edge of the cells (Fig. 26A).
The localization of EBP50 and pERM to one SC process tip in bipolar cells and at
the rear of the unipolar cell suggests that ERM activation may be asymmetrically
associated with the retracting SC process.  To address this issue, we used an EBP50-GFP
construct, which will bind only to activated ERM proteins (Reczek et al., 1997; Reczek
and Bretscher, 1998).  We found that EBP50 localization to the SC distal tip was the first
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Figure 26 - Asymmetric pERM and EBP50 localization at SC tip and trailing edge
involved in process retraction and migration, respectively
A) Both pERM and EBP50 asymmetrically localized to one distal tip of bipolar SCs (top
panels) and the rear of unipolar SCs (bottom panels) transfected with GFP (M6/t5).
Insets show the localization of pERM and EBP50 to filopodia-like retraction fibers at the
SC distal tip.  Asterisks denote nuclear positioning for spatial reference.  B) EBP50-GFP-
transfected SCs (M7/t6) were imaged as described.  Process retraction proceeded as
described with GFP alone.  However, a clear flash of EBP50 could be seen at the tip of
the retracting SC process.  Still images show an elapsed time of 105 minutes.  See also
Fig26Bvideo10-EB-PR.mov.  C) After achieving unipolarity, the EBP50-GFP-transfected
SCs (M7/t6) then migrated as predicted by GFP studies.  Still images span an elapsed 350
minutes.  See also Fig26Cvideo11-EB-MIG.mov.  D) As seen with GFP alone, EBP50-
transfected SCs (M7/t6) are capable of cycling though process retraction, migration, and
process extension.  Still images represent an elapsed 595 minutes.  See also
Fig26Dvideo12-EB-cycle.mov.  Arrows indicate the directionality of process retraction
or migration.  Scale bar=10 µm.
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visually discernable step in SC process retraction (Fig. 26B, supplemental material
Fig26Bvideo10) with 92.2±4.6% of cells presenting this EBP50 localization undergoing
retraction.  The ensuing long, filopodial structures (Fig. 26A, insets) were often left
behind during process retraction.  Hence, they are likely to represent novel manifestations
of retraction fibers.  These asymmetric, distal enrichments of EBP50/ERM provide the
first molecular markers defining a transient inequality of the SC bipolarity that
specifically denotes which SC process will retract generating a mono-oriented,
directionally polarized, migratory cell.
Once retraction had commenced, EBP50 was maintained at the tip of the
retracting process itself and then at the rear of the migrating unipolar cell.  This implies a
sustained region of ERM activation in this process (Fig. 26C-D, supplemental material
Fig26Cvideo11 and Fig26Dvideo12).  Further, discrete EBP50 localization was lost at
the rear of the unipolar cell during process re-extension (Fig. 26D).  This finding suggests
a local signaling switch controlling ERM activation in this morphologic cycling.
We then proceeded to quantify aspects of this unique SC motility.  Over-
expression of EBP50 was not found to significantly increase the frequency of asymmetric
process retraction (Fig. 27A; 45.1±3.8% of either GFP or EBP50-GFP transfected cells
exhibited this phenomenon) and marginally increased the speed of process retraction
(Fig. 28A; GFP - 0.49±0.06 µm/min vs. EBP50-GFP - 0.71±0.1 µm/min, p=0.0685).
However, EBP50 over-expression did significantly enhance the frequency at which
unipolar cells were observed to migrate (Fig. 27B; GFP – 67.8±5.9% vs. EBP50-GFP
95.8±4.2%, p=0.0161) and the rate of unipolar SC migration versus control (Fig. 28B;
GFP – 0.21±0.03 µm/min, EBP50-GFP – 0.40±0.06 µm/min, p=0.0181).
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Figure 27 - Quantification of SC process retraction and migration frequencies
A) Presented is a comparison of the effects of various EBP50 constructs on frequencies
of process retraction in transfected SCs (M5/t4-M8/t7).  Percentages indicate the portion
of transfected SCs that displayed process retraction during time-lapse imaging.  GFP –
43.6±2.6%, EBP50-GFP – 47.7±10.2%, EBP50-70-GFP – 22.0±5.7%, EBP50-PDZ1+2-
GFP – 33.5%, GFP+Y-27632 – 20.5±3.7%, EBP50-GFP+Y-27632 – 22.6±3.2%.
N=number of independent experiments in which a minimum of 68±10 cells were
observed.  B) Presented is a comparison of the effects of various EBP50 constructs on
frequencies of unipolar cell migration in transfected SCs (M5/t4-M8/t7).  Percentages
indicate the portion of transfected SCs that displayed both unipolar morphology and
active, directed migration during time-lapse imaging.  GFP – 67.8±5.9%, EBP50-GFP –
95.8±4.2%, EBP50-70-GFP – 73.6±6.9%, EBP50-PDZ1+2-GFP – 56.7±5.8%, GFP+Y-
27632 – 44.0±20.8%, EBP50-GFP+Y-27632 – 50.0±16.7%.  N=number of independent
experiments in which a minimum of 68±10 cells were observed.
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Figure 28 – Quantification of SC process retraction and migration rates
A) Presented is a comparison of the effects of various EBP50 constructs on rates of
process retraction in transfected SCs (M5/t4-M8/t7).  GFP – 0.49±0.06 µm/min, EBP50-
GFP – 0.71±0.10 µm/min, EBP50-70-GFP – 0.41 µm/min, EBP50-PDZ1+2-GFP –
0.51±0.03 µm/min, GFP+Y-27632 – 0.20±0.05 µm/min, EBP50-GFP+Y-27632 –
0.45±0.04 µm/min.  N=number of individual SCs monitored in at least 3 independent
experiments.  B) Presented is a comparison of the effects of various EBP50 constructs on
rates of unipolar, transfected SC migration (M5/t4-M8/t7).  GFP – 0.21±0.03 µm/min,
EBP50-GFP – 0.40±0.06 µm/min, EBP50-70-GFP – 0.12±0.02 µm/min, EBP50-
PDZ1+2-GFP – 0.23±0.02 µm/min, GFP+Y-27632 – 0.06±0.01 µm/min, EBP50-
GFP+Y-27632 – 0.12±0.03 µm/min.  N=number of individual SCs monitored in at least 3
independent experiments.
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To map the functional domains of EBP50 involved in motility enhancement,
constructs lacking either the ERM binding site (Reczek and Bretscher, 1998) in the
COOH-terminal 70 amino acids (EBP50-70-GFP) or both of the PDZ interaction
domains (Reczek et al., 1997) (EBP50-PDZ1+2-GFP) were generated.  Over-expression
of EBP50-70, as compared with GFP and EBP50-GFP transfection, dramatically
decreased the frequency of asymmetric process retraction to 22.0±5.7% (p=0.0103) (Fig.
27A).  Further, EBP50-70 over-expression substantially impaired unipolar cell migration
rates as compared to both EBP50 over-expression (EBP50-70-GFP - 0.12±0.02 µm/min
vs. EBP50-GFP - 0.40±0.06 µm/min, p=0.0040) and control values (EBP50-70-GFP -
0.12±0.02 µm/min vs. GFP - 0.21±0.0.03 µm/min, p=0.0176) (Fig. 28B).
As we have shown the localization of EBP50 to the distal tip of SCs appears to be
RhoA- dependent (Gatto et al., 2003), we then examined the effect of a ROCK inhibitor,
Y-27632, on SC process dynamics.  ROCK also has been previously shown to affect
neurite retraction and cell motility (Hall, 1998; Kaibuchi et al., 1999a; Nikolic, 2002),
suggesting distinct roles for ROCK in both the SC process retraction and unipolar
migration phases of this motility cycle.  In GFP transfected SCs, Y-27632 reduced both
the frequency (Fig. 27A; GFP – 43.6±2.6% vs. GFP+Y-27632 – 20.5±3.7%, p=0.0012)
and rates (Fig. 28A; GFP – 0.49±0.06 µm/min vs. 0.20±0.05 µm/min, p=0.0056) of
process retraction by more than 50%.  Assessing the active migration phase of this
motility cycle, the inhibitor did not statistically depress the frequency (Fig. 27B; GFP –
67.8±5.9% vs. GFP+Y-27632 - 44.0±20.8%, p=0.2608) of unipolar SC migration.  The
inhibitor did, however, diminish the SC migration rate by 71% (Fig. 28B; GFP –
0.21±0.03 µm/min vs. GFP+Y-27632 – 0.06±0.01 µm/min, p=0.0001).
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The effectiveness of the ROCK inhibitor on process retraction in the presence of
over-expressed EBP50 was not as pronounced.  Y-27632 did not statistically reduce the
process retraction frequency (Fig. 27A; EBP50-GFP – 47.7±10.2% vs. EBP50-GFP+Y-
27632 – 22.6±3.2%, p=0.1574), but did reduce the retraction rate by 37% (Fig. 28A;
EBP50-GFP – 0.71±0.10 µm/min vs. EBP50-GFP+Y-27632 – 0.45±0.04, p=0.0423).
Unipolar SC migration was as substantially affected by ROCK inhibition in the presence
of EBP50-GFP as in the SCs transfected with GFP alone.  The migration frequency of
EBP50-expressing SCs was reduced by Y-27632 (Fig. 27B; EBP50-GFP – 95.8±4.2% vs.
EBP50-GFP+Y-27632 – 50.0±16.7%, p=0.0433), and the unipolar SC migration rate was
diminished by 70% (Fig. 28B; EBP50-GFP – 0.40±0.06 µm/min vs. EBP50-GFP+Y-
27632 – 0.12±0.03 µm/min, p=0.0017).  These results suggest that SC dynamics are
affected not only by EBP50-facilitated interactions but also by Rho pathway activation
via ROCK.
Clues as to how EBP50 may affect SC motility arise from the localization of
active pERMs at the rear of the unipolar cell.  Over-expression of EBP50 significantly
enhanced the percentage of unipolar cells that displayed pERM staining at their rear by
53% versus GFP transfected controls (Fig. 29D, G; GFP - 52.2±2.9% vs. EBP50-GFP -
79.9±2.6%, p=0.0021).  By contrast, over-expression of EBP50-70 severely reduced the
number of unipolar cells exhibiting rear pERM staining (Fig. 29E, G; EBP50-70-GFP –
20.4±4.1%), supporting the idea that EBP50 may be involved in the recruitment of
molecules that play a role in ERM activation.  In contrast to EBP50-70, EBP50-PDZ1+2
was correctly targeted to the tip of the SC process and the rear of the unipolar cell (Fig.
29F).  Surprisingly, this construct also appeared to enhance ERM activation at the rear of
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Figure 29 - EBP50 localization and ERM activation – dependence upon ezrin-binding,
PDZ-mediated interactions, and ROCK activity
A) Full length WT-EBP50, EBP50-70 (lacking its ERM-binding domain), and EBP50-
PDZ1+2 (deleted for the two PDZ binding domains) were transfected into SCs.
Composite images (M6/t5) are shown with EBP50-GFP variants in green, activated,
pERM in red, and co-localization in yellow.  Localizations were assessed at the distal tips
of bipolar SCs and at the rear of unipolar SCs.  Asterisks denote nuclear positioning for
spatial reference.  Scale bar=10 µm.  B) Presented is a quantification of ERM activation
at the cell rear in unipolar SCs after introduction of the specified constructs (M6/t5),
expressed as a percentage of the total number of unipolar cells observed.  GFP –
52.2±2.9%, EBP50-GFP – 79.9±2.6%, EBP50-70-GFP – 20.4±4.1%, EBP50-PDZ1+2-
GFP – 73.8±3.4%, GFP+Y-27632 – 11.1±2.9%, EBP50-GFP+Y-27632 – 32.1±3.0%,
WT-ezrin – 91.4±0.1%, FERM-ezrin – 13.3±0.3%.  Data are representative of 3
independent experiments wherein an average of 81±5 transfected cells were counted per
construct.
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the cell (Fig. 29G), while it did not enhance either asymmetric process retraction or the
rate of unipolar cell motility (Figs. 27, 28).  This result suggests a biphasic regulation
involved in unipolar SC motility.  The bi-functionality of EBP50 enables interactions
involving both the PDZ interaction domains and COOH-terminal region to synergistically
mediate enhancement of directed SC migration.
As the frequency and rates associated with SC dynamics appeared to contain a
distinct Rho-dependent component, we examined whether this was effected via ROCK-
mediated ERM phosphorylation (Matsui et al., 1998).  pERM localization at the rear of
the unipolar SC in the presence of Y-27632 was depressed by 79% in GFP transfected SC
(GFP – 52.2±2.9% vs GFP+Y-27632 – 11.1±2.9%, p=0.0025) and by 60% in EBP50-
GFP transfected SCs (EBP50-GFP – 79.9±2.6% vs. EBP50-GFP+Y-27632 - 32.1±3.0%,
p=0.0013) (Fig. 29G).  Thus, under these conditions, ROCK appears to be a major, but
perhaps not the sole, direct contributor to ERM activation via phosphorylation.
While ROCK has been shown to directly phosphorylate ERM proteins, it also
affects ERM activation by influencing polyphosphoinositide synthesis.  Acting through
PI4, 5 kinase, ROCK activation promotes the generation of the membrane
phosphatidylinositol, PIP2 (Sechi and Wehland, 2000).  PIP2 has been implicated in the
initial stages of ERM activation prior to stabilizing COOH-terminal phosphorylation
(Hirao et al., 1996; Yonemura et al., 2002).  By alleviating the intrinsic conformational
regulation displayed by the head-to-tail association of the ERM NH2- and COOH-
terminal regions (Hamada et al., 2000), PIP2 encourages ERM activation.  However,
PIP2 synthesis can also be achieved via a ROCK-independent mechanism, whereby the
small GTPase Rac interacts with diacylglycerol kinase (Tolias et al., 1998).  This kinase
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generates phosphatidic acid, which readily activates PI4, 5 kinase (Jenkins et al., 1994).
This alternative pathway may explain the incomplete pERM disruption incurred by Y-
27632 in the unipolar SCs.
To determine if PIP2 concentrations are observed at all sites of ERM activation,
we used as a PIP2 reporter a GFP-fused pleckstrin homology (PH) domain of
phospholipase C-delta (PLCδ), which binds to PIP2 with high affinity and selectivity
(Czech, 2000).  In transfected SCs (M6/t5), PLCδ-PH-GFP was localized at the SC
plasma membrane, concentrating asymmetrically at one distal tip in bipolar SCs and at
the trailing edge in unipolar SCs. PLCδ-PH-GFP co-localized with sites of ERM
activation, as detected by pERM staining (Fig. 30A).  This represents the first
demonstration of a spatial and temporal co-localization of PIP2 and active,
phosphorylated ERMs, supporting the idea that PIP2 is involved in ERM activation.
ERM proteins are required for appropriate SC motility and polarity maintenance
Our results suggest a major role for ERM activation in the motility of bipolar SCs,
which contain all three members of the ERM family (Melendez-Vasquez et al., 2001;
Scherer et al., 2001).  To more clearly define the precise role of ERM activity in these
motility-based processes, functional disruption of the ERMs was undertaken. Over-
expression of the ezrin NH2-terminal FERM homology domain perturbs ERM function as
a dominant-negative due to extraordinary sequence conservation (~75% identity among
family members) (Amieva et al., 1999; Crepaldi et al., 1997).  To determine if exogenous
ezrin constructs were correctly targeted within SCs, we co-transfected VSVG-tagged full-
length, WT-ezrin or the FERM domain itself into myelinating explants along with PLCδ-
PH-GFP (M6/t5).  Both constructs co-localized with focal concentrations of PLCδ-PH-
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Figure 30 - PIP2 localizes to specific sites of ERM localization and activation
A) SCs were transfected with a GFP-fused PH domain of PLCδ (M6/t5).  Cultures were
then stained with a phospho-specific ERM antibody, which demonstrates co-localization
with PLCδ-PH-GFP in bi- (upper panels) and unipolar (lower panels) SCs.  B) PLCδ-PH-
GFP was co-transfected with VSVG-tagged WT-ezrin.  Localizations of each protein
were coordinately assessed at the distal tips (upper panels) and rear (lower panels) of bi-
and unipolar SCs (M6/t5), respectively.  C) FERM-ezrin and PLCδ-PH-GFP were
transfected into SCs (M6/t5).  Localizations of both proteins were assessed at the distal
tips (upper panels) and rear (lower panels) of bi- and unipolar SCs, respectively.
Asterisks denote nuclear positioning for spatial reference.  Scale bar=10 µm.
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GFP at one tip of the bipolar SCs and at the rear of the unipolar SCs (Fig. 30B-C).  When
stained for pERM, SCs transfected with WT-ezrin (M6/t5) displayed 91.4±0.1% of
unipolar cells with pERM accumulation at the rear, and the FERM variant depressed
these levels to 13.3±0.3% (p<0.0001) (Fig. 29G).  These results support the idea of the
FERM domain acting as a dominant-negative repressor of endogenous ERM function
potentially competing with endogenous proteins for sites of PIP2 concentration.
While populations of bi- and unipolar SCs were clearly present in SCs transfected
with ezrin variants, there were other remarkable findings with regard to SC polarity.  The
over-expression of WT-ezrin had no overtly adverse effect on SC polarity.  The majority
of the cells maintained their bipolar, singly axon-aligned morphology.  The ezrin FERM
domain, however, induced a significant increase in the number of multipolar SCs with
numerous process extensions associated with various axons (Fig. 31A, C; WT-ezrin
20.2±1.4% vs. FERM-ezrin - 69.3±1.8%, p=0.0001).  When co-transfected with EBP50-
GFP, 94.1±0.4% of EBP50-GFP-positive cells were also VSVG-positive.  Thus, EBP50-
GFP fluorescence visualization was employed and considered sufficient to monitor the
effects of the ezrin constructs on SC dynamics in time-lapse microscopy.
The ezrin FERM domain clearly and dramatically interfered with appropriate SC
motility.  Over-expression of this construct yielded an unresolvable, non-motile,
multipolar phenotype.  Although some cells attempted process retraction, most of these
occurrences were incomplete and unable to re-establish bipolarity.  Despite the multipolar
SCs’ inability to substantially migrate, nuclear oscillations within the SC soma were
frequently observed.  In addition, there were often large, ruffling lamellipodia emanating
from the SC body and/or extended processes (Fig. 31B, supplemental material
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Figure 31 - Functional ERM is required for maintentance of SC polarity and appropriate
motility
A) SCs were transfected with either WT (left) or FERM (right) VSVG-tagged ezrin
(M14/t13).  B) Introducing the FERM-ezrin construct in the presence of EBP50-GFP
(M6/t5), the motility of these cells was monitored.  Multipolarity and gross motility
defects were observed.  Frames presented span an elapsed 495 minutes.  See also
Fig31Bvideo13-DN-ez.mov.  Scale bar=10 µm.  C) Quantitative presentation of
multipolarity induced by transfection of FERM-ezrin as compared to WT-ezrin (M6/t5)
(FERM - 69.3±1.8% vs. WT - 20.2±1.4%).  Data are representative of 3 individual
experiments wherein an average of 696±59 cells were counted per construct.
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Fig31Bvideo13).  Thus, ERM family members are fundamental in regulating SC process
extension and maintaining SC polarity.
Supplemental Material
The time-lapse sequences from which the still images presented in figures 25, 26, and 31
were taken are available for viewing as supplemental material on the provided CD.  More
detailed video descriptions can be found in Appendix II.  Fig25Avideo7 shows process
retraction leading to a unipolar morphology in a GFP-transfected SC.  Fig25Bvideo8 and
Fig25Cvideo9 demonstrate GFP-transfected SCs undergoing unipolar, nucleokinetic
migration and bipolarity re-establishment.  Fig26Bvideo10 illustrates EBP50-GFP
localization coincident with asymmetric process retraction.  Fig26Cvideo11 and
Fig26Dvideo12 show SC migration and morphologic cycling in EBP50-GFP transfected
SCs.  Fig31Bvideo13 demonstrates the multipolarity and process dynamics in a SC co-
transfected with EBP50-GFP and ezrin-FERM constructs.
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Discussion
In this study, we describe a novel form of motility associated with bipolar SCs
migrating in association with axons within myelinating DRG explants.  As represented in
the model shown in figure 32, these cells cycle between static, bipolar and motile,
unipolar morphologies associated with asymmetric process retraction and extension.
Unipolar cell motility exhibits a nucleotaxic characteristic, reminiscent of neurons
migrating on radial glia (Nadarajah et al., 2001; Nadarajah and Parnavelas, 2002).  Using
GFP fusions of EBP50 as indicators of sites of ERM activation, we observed that these
proteins are activated at the tip of the retracting process and concentrated at the rear of
the migrating cell.  At these sites, ERM proteins co-localized with concentrations of the
membrane phospholipid PIP2, considered to be an upstream trigger for ERM activation.
Over-expression of EBP50 enhanced unipolar cell movement, suggesting a new role for
this adaptor protein in cell motility.  Finally, perturbation of ERM function interfered
with both process retraction and cell motility, causing SCs to lose their characteristic
bipolar shape and assume a multipolar morphology.
Let us first examine process retraction and the relationship between uni- and
bipolarity in terms of their necessity in SC migration.  Approximately 46% of bipolar
SCs retract one distal process and begin directed, unipolar migration.  This form of
motility appears to obligately require the retraction of one distal process prior to the
commencement of gross cell movement.  This suggests that the uni- and bipolar SCs
observed in the DRG explants simply represent distinct polarity states through which the
SCs may cycle.  However, the 54% of SCs that do not undergo process retraction
maintain their bipolarity and are, primarily, non-motile.  This conversely suggests that
Process extension
Process retraction Migration
PIP2 synthesis/ERM activation/EBP50 recruitment
Figure 32 - Model - SC motility cycle
131
Figure 32 – Model - SC motility cycle
As SCs align themselves along axons and probe their local environment, migration may
be required in the absence of stabilizing signals that indicate appropriate positioning.
Rho activation and PIP2 synthesis may initiate this process.  Upon PIP2 (blue squares)
concentration, ERM stabilization and activation (orange), and EBP50 (red) localization to
a given actin (green) enriched SC tip, this process of the SC retracts.  This is often clearly
visualized by the trailing of a distinct retraction fiber.  This process retraction generates a
motile, unipolar SC that migrates in a neuron-like manner.  As these unipolar SCs
migrate, PIP2, ERM, EBP50, and actin concentrations are retained.  Upon the encounter
of an appropriate stimulus, the accumulations of these components at the cell rear
dissipate, and process extension re-establishes SC bipolarity.
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there may in fact be two classes of SCs at the onset of myelination in the DRG explants,
which at least differ in their motility response to global application of serum and
ascorbate.
Differentiating between these two hypotheses may be possible by exploiting the
asymmetric nature of the apparent signaling that leads to unipolar migration.  If all SCs
possess the molecular machinery to enable the cycle of process retraction and unipolar
migration, perhaps appropriate cue encounter is the limiting factor.  Then, directly
promoting localized ERM activation and EBP50 recruitment may be sufficient to trigger
the predicted motility response.  To facilitate discrete, enhanced Rho signaling or PIP2
accumulation, localized application of either LPA or free PIP2, respectively, to one distal
tip of a non-motile, bipolar SC, could be employed.
If the otherwise static SCs do not respond to this treatment, it is possible that
qualitative differences exist among sub-populations of these cells.  Precedents for this
type of relationship can be fundamentally derived from the fact there are, indeed, both
myelinating and non-myelinating SCs in vivo.  We have not examined the relative
contribution of each class of SCs to the explants’ glial composition, nor have we
examined the specific developmental phenotype of the migratory SCs.  Utilizing the
characteristic molecular signatures of myelinating and non-myelinating SCs, we may be
able to correlate myelinating status with motility phenotype.
One of the most striking features of the novel SC motility described in this study
is its similarity to the migration of neurons on radial glia (Nadarajah et al., 2001;
Nadarajah and Parnavelas, 2002).  SCs are proposed to acquire their elongated bipolar
morphologies from alignment with axons.  The similarity in motility mechanisms may
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reflect morphological constraints imposed on cells migrating in association with long,
extended substrates, such as axons or radial glia.  Support for this stems from our studies
of early DRG explant development (Gatto et al., 2003).  In the first week of culture, SCs
migrating from the body of the explant have not yet acquired a bipolar morphology and
look fibroblastic in nature.  In these cells, active ERM proteins are distributed through the
perimeter of the cell, sometimes accumulating at the leading edge, rather than the rear of
the migrating cell (Chapter 4, Fig. 16).  These observations suggest that the function of
active ERMs at the rear of the migrating cell may be peculiar to the developmental
staging and morphology of the mature, elongated SC.
The functions of active ERM proteins at the rear of the migrating unipolar cell are
unknown.  These proteins appear to be associated with active filopodia at the rear of the
cell, which might be involved in environmental sensing as the cell advances.  Such a
“rear-facing” growth cone could be important for process extension, ensuring that the SC
is able to maintain its alignment with the axon when bipolarity is re-established.
Alternatively, ERM proteins have been extensively implicated in cell adhesion (Bretscher
et al., 2002; Louvet-Vallee, 2000; Mangeat et al., 1999), and their localization at the rear
of the migrating unipolar cell could reflect a role in the release of rear adhesions
necessary for the forward movement of the cell.  This concept is evidenced by studies of
moesin function in the trailing uropod of migrating neutrophils (Yoshinaga-Ohara et al.,
2002).  Here, the Rho-mediated retraction of the uropod is achieved via spatiotemporal
regulation of moesin phosphorylation.  The nature of the adhesions potentially mediated
through ERM proteins in SC motility also remains unknown.  However, N-cadherin is
concentrated at the SC process tip during the early stages of SC-axon alignment (Wanner
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and Wood, 2002), and perturbations of N-cadherin mediated SC-axonal contacts in
SC/DRG co-cultures result in a multipolar SC phenotype similar to those reported herein
upon ERM perturbation.
In this study, we demonstrate, for the first time, a definitive role for the ERM
adaptor protein EBP50 in cell motility.  Over-expression of EBP50 enhances unipolar
cell motility.  This enhancement is dependent upon the presence of the molecule’s PDZ
domains.  Similarly, over-expression of the PDZ domains of EBP50 alone in the absence
of the ERM binding region inhibits both process retraction and unipolar cell motility,
suggesting that EBP50 recruits molecules to sites of active ERMs that facilitate motility.
We are intrigued as to why the EBP50-PDZ1+2-GFP construct does not behave as a
dominant-negative for EBP50 function, as is observed with the EBP50-70-GFP construct.
This may reflect differences in the stoichiometries or affinities of interactions involving
the ERM binding site and the PDZ domains.  Also, EBP50-70 appears to inhibit the
accumulation of pERMs at the rear of the unipolar cell, whereas EBP50-PDZ1+2
enhances this effect similarly as to what is observed with wild type EBP50.  Thus, EBP50
functions as a bi-modal adaptor and mediates differential, but equally necessary,
interactions leading to appropriate unipolar cell motility.
Understanding these intricacies awaits further identification of the role of EBP50
in cell motility.  However, clues as to this function arise from recent observations of an
interaction between EBP50 and Rack1 (Liedtke et al., 2003; Liedtke et al., 2002).  Rack1
has been extensively implicated in cell motility and binds to both β1 integrin and
isoforms of PKC (Besson et al., 2002; Buensuceso et al., 2001; Liliental and Chang,
1998; Schechtman and Mochly-Rosen, 2001).  As ezrin has been identified as an effector
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for integrin-mediated signaling through PKC (Ng et al., 2001), EBP50 may then provide
an important link between integrin-mediated cell signaling and ERM activation.
In addition, with the identification of the SC EBP50/ERM-enriched cap structure
as a novel indicator of SC process retraction, and not necessarily a stable precursor to SC
microvilli, we must reassess the correlation between cap and node formation previously
described (Chapter 4, Fig. 21).  Culture conditions that enhance SC cap formation do
indeed lead to the more efficient generation of SC microvilli.  However, these results, in
light of the cap-associated SC dynamics, implicate a novel role for SC motility in
achieving proper myelination.  Further characterization of SC motility may lead to
advances in understanding the elusive mechanics involved in the initiation of
myelination.
The functionality of unipolar cell motility in myelination and its initiating signals
remain unknown.  We have observed that SCs are highly dynamic and exhibit localized
concentrations of RhoA (Chapter 4, Fig. 18) (Gatto et al., 2003).  Enriched in this
signaling molecule, the SC tips themselves may represent the sensors that initiate process
retraction.  Signals that initiate this event could include axonal contact or contacts with
other SCs.  The number of unipolar cells observed in myelinating DRG explants falls as
the cultures mature and myelination progresses, suggesting a role for this form of motility
in the early events of the myelination program.  This program requires the defining of
precise internodal lengths that, to some extent, must reflect the regular periodic spacing
of SCs along the length of the axon.  Unipolar cell motility and asymmetric process
retraction and extension could play a role in achieving this regular alignment of SCs
along the axon prior to the elaboration of myelin sheaths.  In support of this, we have
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observed unipolar MAG-positive myelinating SCs.  This suggests that the general
bipolarity of a myelin segment could result from the delayed elongation of a unipolar
segment, rather than from SCs achieving obligate bipolarity prior to the onset of
myelination.  As elongation and compaction of the myelinating SC have been proposed to
influence the organization of the axo-glial interface (Pedraza et al., 2001), then process
re-extension from the unipolar myelinating cell may be fundamental to factors such as
nodal organization.
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Chapter 6
Discussion and Future Directions
Functionality of EBP50 and Schwann cell caps
Localization of Kv1.5
Cell adhesion/alignment mediated via N-cadherin
Syndecans and membrane-associated complexes
Exploitation of retroviral infection
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Myelination is a specialized, intricate process that involves the intimate
association of the myelinating glial cell with its target axon.  Neural functionality is
critically dependent upon the successful generation of myelin segments and associated
nodes of Ranvier which coordinate rapid, saltatory action potential conduction.  The
findings presented herein describe and begin to functionally define the PNS’ axo-glial
interactions mediated by SC caps upon the induction of myelination.  These ERM and
EBP50-enriched structures have been linked to appropriate SC process dynamics, SC
motility, and efficient node formation.  One key question that remains to be answered is
what the precise role of EBP50 is in these structures and in SC microvilli proper.
EBP50 is situated to mediate directed targeting and retention of specific
membrane proteins to the distal tips of the SC with its two PDZ binding domains and
ezrin binding capability (Reczek et al., 1997).  EBP50 becomes localized to the nodes of
Ranvier in the SC microvilli, which are in close association with the underlying axonal
membrane in myelinated tracts.  This axonal region undergoes dramatic and repetitive
membrane depolarization as action potential propagation continues.  To moderate this
constant electrical flux, EBP50 could serve to localize appropriate ion channels to the
nodal gap that could facilitate ionic buffering.
Our preliminary data suggests that EBP50 may interact with the voltage-
dependent, Shaker-like, delayed-rectifying potassium channel, Kv1.5, upon the induction
of myelination.  Co-localization of endogenous EBP50 with a T7-tagged Kv1.5 variant
has been demonstrated at the microvillar component-enriched SC distal tips (Fig. 33).
Although Kv1.5 has been previously localized to mature SC microvilli (Mi et al., 1995),
its interacting partners there were never identified.  However, the COOH-terminal amino
EBP50T7-Kv1.5
T7-Kv1.5-ETDL EBP50
d21/M6/ t5
Figure 33 - Kv1.5 co-localizes with EBP50 at SC tips
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Figure 33 - Kv1.5 co-localizes with EBP50 at SC tips
SCs were transfected with T7-tagged-Kv1.5 (A) and immunostained for endogenous
EBP50 (B).  At d21/M6/t5, co-localization was evident at the SC distal tip (composite C,
arrowheads) and appeared to be, at least partially, dependent upon the PDZ-binding motif
(-ETDL) of Kv1.5.  Transfected Kv1.5-ETDL (D) resulted in diminished detectable
Kv1.5 at the EBP50-reactive (E) SC tip (composite F, arrows).  Scale bar=10 µm.
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acid sequence of Kv1.5 (–ETDL) closely approximates one derived consensus sequence
for binding to EBP50’s PDZ domains (-D-S/T-X-L) (Wang et al., 1998).  Further, in
support of this proposed PDZ-mediated interaction, removal of either the PDZ domains
of EBP50 or the –ETDL PDZ-binding sequence of Kv1.5, specifically abrogates their co-
localization in SCs (Figs. 34, 35).
These data and our preliminary biochemical examination (unpublished data, B.
Walker, Lambert Lab) indicate that EBP50 generally may serve as a scaffold for the
linkage of Kv1.5 to cytoskeletal components.  This link could be indispensable for the
appropriate electrical responsiveness of mature myelinated nerves. Our data implicate
Kv1.5 as being resident at the distal tip of a retracting SC process rather than in a static
structure, as defined by EBP50 enrichment being linked to process instability.  How
Kv1.5 functions in the morphologic plasticity exhibited by SCs remains to be determined,
but it has been shown that Kv1.1 and 1.5 over-expression in intestinal epithelial cells
promotes membrane hyperpolarization and a 4-fold increase in cellular migration rates
(Rao et al., 2002).  Perhaps then, Kv1.5 is promoting enhanced motility of the SC process
with its focal concentration specifically residing at the distal tip of the cell.
Impairing the ionic activity of Kv1.5 by introducing specific inhibitors of this
channel would allow us to test this hypothesis.  The pharmacologic agent, tyrphostin AG-
1478, acts as a potent protein tyrosine kinase inhibitor and rapidly, reversibly inhibits
Kv1.5 currents in a concentration-dependent manner (Choi et al., 2002).  4-
aminopyridine also inhibits Kv1.5.  This inhibition is pulse-frequency-dependent and is
associated with a positive shift in activation voltage dependence (Kerr et al., 2001).
Treating the explant cultures with these compounds may provide insight as to whether
T7-Kv1.5 EBP50-GFP
T7-Kv1.5-ETDL EBP50-GFP
T7-Kv1.5 EBP50-PDZ1+2-GFP
d21/M6/ t5
Figure 34 - Kv1.5 localization is dependent upon
its ETDL motif and the PDZ-binding domains of EBP50
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Figure 34 - Kv1.5 localization is dependent upon its –ETDL motif and the PDZ-binding
domain of EBP50
SCs were transfected with variants of Kv1.5 and EBP50 to address the domain
requirements for their co-localization.  Full length T7-Kv1.5 co-localized with full length
EBP50-GFP (A-C) at SC distal tips.  The co-localization of these two constructs was
reciprocally dependent upon the presence of the PDZ binding motif of Kv1.5 (-ETDL)
(D-F) and the PDZ domains of EBP50 (G-I).  Arrowheads denote SC caps.  Scale
bar=10µm.
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Figure 35 – Quantification of Kv1.5 cap localization
A) Quantitative assessment of Kv1.5-enriched, EBP50-positve SC caps in DRG explant
cultures.  The basal level of Kv1.5 transfected SCs with EBP50-positive caps (detected
by either EBP50-GFP or EBP50 immunoreactivity) was determined examining Kv1.5
transfected cultures under standard conditions and set at 1=0.66%.  This minimal
percentage was further reduced by the introduction of the Kv1.5 variant lacking its
COOH-terminal PDZ binding motif (-ETDL).  Upon the induction of myelination, the
percentage of Kv1.5/EBP50-reactive caps increased 6.6-fold, which was dependent upon
the ability of Kv1.5 to interact with EBP50.  B) Presented is a quantitative analysis of the
PDZ-mediated dependence of the co-localization of Kv1.5 and EBP50.  Using EBP50-
GFP enrichment at the SC distal tip as the normalizing indicator of cap formation, the
percentage of Kv1.5/EBP50 co-localization was determined.  Assuming the maximal
number of caps is detectable in EBP50-GFP transfections and taking this value to
represent 100%, which itself in these studies occurred in 12.0±0.1% of transfected cells,
48.9% of caps displayed co-localization of T7-Kv1.5 and EBP50-GFP.  This was reduced
to 28.3% by removing the PDZ binding domain of EBP50 and to 14.6% by removing the
PDZ-binding capability of Kv1.5.  The lowest percentage of co-localization (13.1%) was
seen with the co-transfection of the two mutually PDZ interaction deficient protein
variants (EBP50-PDZ1+2-GFP and T7-Kv1.5-ETDL).
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Kv1.5 activity is required in promoting SC migration.  It also may be helpful to introduce
these effectors in the presence of SCs transfected with EBP50-GFP to specifically
monitor cap dynamics, as Kv1.5 concentrates at the SC distal tips.
Examining other EBP50/ion channel interactions that may be involved in SC
migration, EBP50 is known to bind the Na+/H+ exchanger isoform 3, NHE3, which
enables the electroneutral counter-transport of H+ for Na+ across the plasma membrane
(Reczek et al., 1997; Weinman et al., 1993).  A link established between pH and cellular
morphology indicates that rounding cells are 0.15 pH units more acidic than spreading
cells (Schwartz et al., 1989).  Thus, cell spreading increases intracellular pH.
Considering SC process retraction as the antithesis of spreading, we predict acidification
at the SC tip may be required.  This could be specifically mediated by down-regulation of
NHE3 and/or other local Na+/H+ antiporters.  Thus, the EBP50 concentration at the SC tip
may be serving to mediate the turnover and removal of NHE3 from the membrane.
To directly address whether this EBP50 binding partner has a role in SC
dynamics, we propose disrupting the functionality of NHE3 in these cells.  In fact,
treatment of epithelial cells with toxin B of Clostridium difficile causes inhibition of
NHE3 activity, with decreased NHE3 activity being accompanied by the translocation of
exchangers to a subapical endomembrane compartment (Hayashi et al., 2004).  In
addition, NHE3 is acutely inhibited by the cholinergic agonist carbachol, which prompts
elevation of the intracellular concentration of free calcium ions (Lee-Kwon et al., 2003).
If these NHE3 inhibitors are applied to myelination-induced DRG explants, we may be
able to promote more rapid SC process retraction and/or migration by forcing the cells to
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become generally acidotic.  However, global shifts in pH may be insufficient in
mediating localized effects at the distal tip of bipolar and at the rear of the unipolar SCs.
Lastly, if pH itself is found to be of significance, in terms of mediating process
retraction and migration, loading SCs with a pH-sensitive, ratiometric, fluorescent dye
may prove useful.  2',7'-Bis(2-carboxyethyl)-5(6)-carboxyfluorescein (BCECF) can be
introduced into cells as a nonfluorescent membrane-permeant acetoxymethyl ester,
BCECF-AM.  Upon hydrolysis, BCECF-AM becomes a membrane impermeable, free-
acid derivative (Paradiso et al., 1984; Thomas, 1986).  BCECF has a pKa of 6.97,
permitting an ideal dynamic range for monitoring pH changes in an intracellular
environment with high sensitivity.  By monitoring SCs loaded with this dye, we may be
able correlate localized changes in intracellular pH and specific motility responses,
including process retraction and migration itself.
Considering EBP50 in terms of its influence on SC dynamics, we must further
note that cell migration generally requires the extension of a leading process, formation
and stabilization of forward adhesions, contraction and advancing of the cell body, and
disassembly of rear adhesions (Horwitz and Parsons, 1999).  The localization of this
membrane adaptor protein to the distal tips of retracting SC processes and to the rear of
the migrating unipolar cell implies that EBP50 could aid in localizing components that
function in mediating the dissolution of adhesive interactions required to propel the SC
forward.  Our initial studies have demonstrated the co-localization of EBP50 and/or
pERM at SC distal tips in 65.4±3.4% of cap-presenting cells with the cell adhesion
molecule N-cadherin (Fig. 36).
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Figure 36 - N-cadherin localizes to the SC distal tip
A) The potential association of adhesive components with the SC distal tip/cap was
examined in isolated SCs.  Immunostaining with EBP50 or phospho-ERM (red) revealed
the frequent co-localization of N-cadherin (green) in areas enriched with these
microvillar components.  Scale bar=10 µm.  B) Quantitatively, 65.3±3.4% of the SC caps
were reactive for either EBP50 or phospho-ERM and N-cadherin, while 34.7±3.4% were
reactive only for either EBP50 or phospho-ERM.  These data represent the average of
two independent coverslips examined that were derived from the identical preparation of
SCs.
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Cadherins mediate cell-cell adhesion via extracellular, calcium-dependent
homophilic interactions.  Their intracellular regions interact with cytosolic α- and β-
catenins.  β-catenin serves as a bridge between cadherin and α-catenin, and α-catenin
links the complex to the actin filament network (reviewed in Fukata and Kaibuchi, 2001;
Kaibuchi et al., 1999b).  Together these sets of interactions enable the formation of stable
cell-cell adhesions.  By protein interaction screening, EBP50 has been identified as a β-
catenin-associating molecule (Shibata et al., 2003), with β-catenin harboring a PDZ-
binding consensus sequence (-DTDL).  Achieving interaction with and sequestration of
β-catenin, EBP50 could down regulate N-cadherin mediated cell-cell contacts by
disrupting α- and β-catenin interactions.
Both PNS and CNS myelination studies indicate that N-cadherin functions to
support contact-mediated, axo-glial alignment of both myelinating SCs and
oligodendrocytes, respectively (Schnadelbach et al., 2001; Wanner and Wood, 2002).
These studies would suggest that uncoupling N-cadherin signaling could generate a less
axon-adhesive, more motile SC.  In practice, N-cadherin perturbation leads to 59% of
exogenous SCs becoming misaligned with respect to co-cultured DRG axons, with SCs
assuming either a multipolar or non-processed, “non-polar” phenotype (Wanner and
Wood, 2002).  As the multipolarity closely approximates our results following ERM
disruption, SCs with perturbed N-cadherin signaling may alternatively exhibit impaired
motility.  Thus, global N-cadherin disruption studies may not clearly identify the role of
N-cadherin in SC process dynamics.  However, the effect of this cell adhesion molecule
on overall SC motility has not yet been addressed.
Another line of evidence, which focuses on identifying the molecular complexes
that define EBP50’s functionality in SC processes, involves the syndecans.  The
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transmembrane, heparan sulfate proteoglycans, syndecan-3 and -4, were shown to
localize to the perinodal region of myelinating SCs (Goutebroze et al., 2003).  These
proteins function as modulators of ligand-dependent activation of primary signaling
receptors at the cell surface (reviewed in Carey, 1997).  Further, syndecan-3 is most
abundant during the late embryonic and early postnatal periods of peripheral nerve
development and binds to the non-collagenous NH2-terminal domain of alpha 4 (V)
collagen, which mediates heparan sulfate-dependent SC adhesion.  Syndecan-3 is
susceptible to matrix metalloproteinase-dependent membrane shedding, which modulates
its function (Asundi et al., 2003).  Syndecan-4 binds fibronectin (Woods and Couchman,
2001) and in conjunction with α5β1 integrin promotes stress fiber and focal adhesion
formation (Wilcox-Adelman et al., 2002).  However, the interaction of syndecan-4 with
an ECM component tenascin-C, which is present in the nodal gap under the SC basal
lamina (Martini et al., 1990; Rieger et al., 1986), decreases adhesion (Huang et al., 2001).
As the syndecans modulate adhesion based on local environment, they are well
suited to functionally dictate either process retraction or extension in SC cycling.
Linking the syndecans to the SC cap, syndecans bind ezrin through a conserved motif
originally identified in syndecan-2 (Granes et al., 2003; Granes et al., 2000).  As these
ezrin-binding proteins are present in the mature, node-associated microvilli, we speculate
that they reside at the microvillar component-enriched SC cap that functions in SC
process dynamics and motility.  Functionally, the COOH-terminal region of syndecan
interacts with the PDZ domain-containing protein syntenin (Grootjans et al., 1997),
which binds PIP2 (Zimmermann et al., 2002).  Syndecan-4, then, is capable of binding
and activating PKC in the presence of PIP2 (Bass and Humphries, 2002).
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As indicated in Chapter 5, an activated-PKC interactor implicated in cell motility
is Rack1.  Rack1 binds not only to PKC, but also to EBP50 and β1 integrin (Besson et al.,
2002; Buensuceso et al., 2001; Liedtke et al., 2003; Liedtke et al., 2002; Liliental and
Chang, 1998; Schechtman and Mochly-Rosen, 2001).  Further implicating cap-resident
proteins potentially involved, ezrin itself has been identified as an effector of integrin-
mediated signaling through PKC (Ng et al., 2001).  In addition, syndecan-4 interacts with
β1-integrin (Wilcox-Adelman et al., 2002), and β1 integrin is critical in the extension and
maintenance of SC processes along axons (Feltri et al., 2002).  Therefore, EBP50 may
provide an important bridge between integrin-mediated cell signaling and ERM
activation and function with the aid of Rack1 and the syndecans generating a key multi-
molecular complex at the SC membrane.
In terms of examining the role of the axo-glial interactions themselves in
peripheral nerve development, our results indicate a functional coupling of components
that mediate the generation of mature SC microvilli (EBP50 and ERMs) and these cells’
specific modes of motility at the onset of myelination.  This hypothesis suggests a
revisiting of genetic mutations known to generate abberant SC microvilli, i.e. the
dystroglycan mutant mouse (Saito et al., 2003), and a reassessment of the motile
properties of the SCs in these backgrounds.
Dystroglycan is expressed in SCs perinatally just prior to the onset of myelination
and binds laminin-2, which is a component of the SCs’ specialized ECM, the basal
lamina (Previtali et al., 2003).  Further, in myelinating SCs, dystroglycan interacts with
the dystroglycan-related protein 2 (DRP2), a dystrophin isoform (DP116), and utrophin.
Utrophin links the complex to the actin-based cytoskeleton (Sherman et al., 2001).
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Disruption of these interactions by selective SC dystroglycan deletion in mice is known
to impair microvilli formation and nodal clustering (Saito et al., 2003).  It would be of
significant interest to determine if dystroglycan-null SCs also posses a resultant
disruption in motility.  This could provide evidence of a key relationship between SC
motility and appropriate node of Ranvier formation mediated via a bi-functionality of
microvillar components, perhaps by allowing for correct SC positioning at the onset of
myelination and nodal organization at later stages.
The myelinating DRG explant culture system has proven to be extremely
powerful.  The capability of transfecting axon-associated glial cells has enabled the study
of effectors influencing SC development, differentiation, and motility.  However, peculiar
limitations did present themselves.  Most importantly, despite the occasional transfected
cell being engaged in active myelination, glial cell transfection appears to impede
myelination.  We were able to examine the generation and maturation of myelin segments
and nodes of Ranvier in general.  However, we were unable to effectively address the
consequences of molecular perturbations on these processes utilizing exogenous protein
introduction.
In pursuit of future experiments to extend these studies, an effective, under-
exploited avenue involves the retroviral infection of DRG-originating SCs in the explant
cultures (Howe and McCarthy, 1998).  Our preliminary usage of GFP-based retroviral
constructs allowed for not only the visualization of GFP-positive myelin but also these
segments associated with discrete nodal specializations (Fig. 37).  By employing a
dicistronic retroviral vector enabling a protein of interest to be followed by an internal
ribosomal entry site (IRES) and GFP, two open reading frames are generated, each of
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Figure 37 - Retroviral infection produces GFP-positive myelin segments
A) Using IRES-GFP based retroviruses, DRG explants were infected and examined after
the induction of myelination.  After 17 days induction (d39/M17), GFP-positive SCs
were visualized via fluorescence and differential interference contrast (DIC) microscopy,
indicating that the infection did not interfere with myelin segment generation.  B) To
ensure that retroviral infection did not impair node formation, cultures (d53/M21) were
immunostained for MBP (blue) and ankyrinG (red).  GFP-expressing SCs involved in
segment formation were identified and appropriate nodal clusters of ankyrinG were
present.  Scale bar=10 µm.
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which can be independently translated.  This would specifically allow for the
determination of the effect of a particular protein by the identification of GFP-positive
cells.  Further, the retroviral employment does not itself impair myelination or node
formation, allowing for the study of terminal phenotype effects in these processes.
Despite the significant role we have identified for microvillar components in SC
development and function, the most significant finding reported thus far in the NHERF-1
(EBP50) knockout mouse appears to be disrupted localization of the sodium-phosphate
transporter, Npt2, in the renal proximal tubule cells paired with resultant phosphate
wasting.  These animals also display muscle weakness and impaired mobility (Shenolikar
et al., 2002), suggesting potential neuromuscular deficits.  As we have shown significant
correlations among SC cap formation, SC motility, and node formation, further study of
these animals should provide key insights as to the role of EBP50 and SC microvilli in
the functioning of the PNS.  These findings could potentially aid in the therapeutic
facilitation of SC motility, prompting repair mechanisms in both neural injury and
disease states.
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Appendix I – Abbreviations
AnkB – ankyrinB
AnkG - ankyrinG
BCECF - 2',7'-Bis(2-carboxyethyl)-5(6)-carboxyfluorescein
BME – Basal Medium Eagle’s
C-ERMAD - COOH-ERM association domain
CFTR – cystic fibrosis transmembrane receptor
cm – membrane capacitance
CMT – Charcot-Marie-Tooth disease
CNS – central nervous system
COOH - carboxy
DIC – differential interference contrast
DN – dominant negative
DRG – dorsal root ganglion
EBP50 – ezrin binding phosphoprotein 50kDa
ECM – extra-cellular matrix
E”N” – embryonic day N
ERM – ezrin-radixin-moesin family proteins
FERM – four point one, ezrin, radixin, moesin
GalC - galactocerebroside
GPI – glycosyl-phosphatidylinositol
HBSS – Hanks’s Balanced Salt Solution
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LPA – lysophosphatidic acid
MAG – myelin-associated glycoprotein
MBP – myelin basic protein
N-ERMAD – NH2-ERM association domain
NH2 – amino
NHE3 – Na+/H+ exchanger isoform 3
NHERF-1 – NHE3 regulatory exchange factor 1
PBS-T – phosphate-buffered saline with 0.2% trition X-100
PDZ - PSD-95/DlgA/ZO-1
pERM – phospho-ERM
PH – plekstrin homology
PI 4, 5 kinase -  phosphatidyl inositol 4-phosphate 5 kinase
PIP2 - phosphatidylinositol (4,5)-bisphosphate
PLCδ - phospholipase C delta
PMP22 - peripheral myelin protein 22 kDa
P”N” – post-natal day N
PNS - peripheral nervous system
PKC - protein kinase C
P0 - protein zero
ra – axial resistance
ROCK – Rho-associated kinase
SC – Schwann cell
SEM – standard error of the mean
159
vgsc – voltage-gated sodium channel
VSVG – vesicular stomatis viral G protein
WT – wild-type
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Appendix II - Supplemental Video Legends
Video1 – DRG Culture Establishment
Acutely isolated DRGs (d1) were imaged to visualize culture establishment.  Using DIC,
growth cones originating at the DRG explant can be seen migrating through the field of
view.  An initial SC followed by a wave of these cells is apparent migrating in close
association with the axons.  The video clip then advances to approximately 40 hours, and
several rounds of SC division are clearly observed.  Images were captured every 7
minutes and are shown at 5 frames/sec.
Fig15video2 – Node of Ranvier
This video shows an animated, volumetric rendering of a deconvolved Z-series through a
node of Ranvier.  The myelinated culture (d36/M15) was stained for MBP (blue),
ankyrinG (green), and EBP50 (red).  Note the EBP50-reactive SC microvilli
encompassing the axonal ankyrinG staining at the node.  The field rotates and the nodal
components alternately fade to better demonstrate their spatial relationship.  Special
thanks to Brian Schneider (Improvision) for assistance in employing OpenLab and
Volocity software to generate these images.
Fig17video3 – EBP50-GFP SC – Standard – Short Term
EBP50-GFP transfected cultures were examined via time-lapse microscopy.  Transfected
SCs in standard cultures (d29/t7) showed no specific localization of EBP50-GFP at their
161
tips.  Images were captured every 3 minutes over a 60-minute period.  The video is
shown at 360x real-time (2 frames/sec).
Fig17video4 – EBP50-GFP Standard Tip
Focusing on the SC tip, there is no enrichment of EBP50-GFP in this area under standard
conditions (d29/t7).  Images were captured every 3 minutes over a 60-minute period.  The
video is shown at 360x real-time (2 frames/sec).
Fig17video5 – EBP50-GFP Myelin – Short Term
EBP50-GFP transfected cultures were examined via time-lapse microscopy.  Transfected
SCs in myelinating cultures (d29/M6/t5) had dynamic, remodeling EBP50-GFP positive
tips.  Images were captured every 3 minutes over a 60-minute period.  The video is
shown at 360x real-time (2 frames/sec).
Fig17video6 – EBP50-GFP Myelin Tip
Under myelinating conditions (d29/M6/t5), EBP50-GFP becomes highly localized to the
actively restructuring cap region.  Images were captured every 3 minutes over a 60-
minute period.  The video is shown at 360x real-time (2 frames/sec).
Fig25Avideo7 – SC process retraction - GFP
After induction of myelination, GFP-filled SCs (d27/M6/t5) demonstrate asymmetric
process retraction generating a unipolar morphology. Images were captured every 5
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minutes, and this video spans an elapsed 95 minutes, shown at 1500x real time (5
frames/sec).
Fig25Bvideo8 – SC migration – GFP
GFP-filled SCs (d27/M6/t5), upon attaining a unipolar state, undergo nucleokinetic,
directed migration.  Images were captured every 5 minutes, and this video spans an
elapsed 600 minutes, shown at 1500x real time (5 frames/sec).
Fig25Cvideo9 – SC cycling – GFP
GFP-transfected SCs (d27/M6/t5) are able to re-establish bipolarity via process
extension. Images were captured every 5 minutes, and this video spans an elapsed 600
minutes, shown at 1500x real time (5 frames/sec).
Fig26Bvideo10 – SC process retraction - EBP50-GFP
EBP50-GFP (d28/M7/t6) becomes highly localized to the SC distal tip in conjunction
with process retraction.  EBP50-GFP enrichment at a SC distal tip visually marks that
process for retraction.  Images were captured every 5 minutes, and this video spans an
elapsed 150 minutes, shown at 1500x real time (5 frames/sec).
Fig26Cvideo11 –SC migration - EBP50-GFP
EBP50-GFP transfected SC (d28/M7/t6) showing EBP50 localization at one distal tip,
associated process retraction, and subsequent unipolar migration.  Images were captured
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every 5 minutes, and this video shows an elapsed 595 minutes, shown at 1500x real time
(5 frames/sec).
Fig26Dvideo12 - SC cycling - EBP50-GFP
EBP50-GFP expressing SC (d28/M7/t6) cycles through polarity states.  This clearly
illustrates the morphologic plasticity these cells possess, undergoing process retraction,
unipolar migration, and process extension re-establishing bipolarity.  Images were
captured every 5 minutes, and this video spans an elapsed 590 minutes, shown at 1500x
real time (5 frames/sec).
Fig31Bvideo13 – Multipolar DN-ezrin (FERM) SC
FERM-ezrin/EBP50-GFP co-transfected SC (d27/M6/t5) displaying severe multipolarity
and impaired motility.  Images were captured every 5 minutes, and this video spans an
elapsed 600 minutes, shown at 1500x real time (5 frames/sec).
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